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CHAPTER I 
 
INTRODUCTION 
 
Introduction 
Bacteria encounter and deftly respond to a myriad of environmental signals, yet only 
have the genomic capacity to encode a finite number of signaling systems that intercept stimuli 
and transduce them to the bacterial cell interior. This work describes one mechanism by which 
bacteria expand their response inventory, using few two-component systems (TCSs).  Using 
uropathogenic E. coli (UPEC) as a model pathogen that occupies multiple host niches, but 
encodes only 35 TCSs, we demonstrate that signaling systems can interact to mediate responses 
to stressors, such as cationic polypeptides.  The research in this dissertation focuses on the cross-
interactions between two closely related bacterial two-component signaling systems, PmrAB and 
QseBC, and the downstream effects, resulting from the interactions.  Chapter II describes the 
discovery that PmrAB and QseBC interact, using a panel of mutants and biochemical approaches 
in the absence of signal. Chapter III provides evidence of QseBC-PmrAB cross-interaction 
during exposure to the signal ferric iron to mediate tolerance to polymyxin B.  Chapter IV 
describes the regulatory mechanism used to control the expression of the QseBC two-component 
system and begins to investigate the conservation of this control mechanism in different 
phylotypes of E. coli.  The ferric iron mediated QseBC-PmrAB global regulon is discussed in 
Chapter V. This thesis offers novel insight into the way bacteria use two-component system 
signaling to respond to relevant stimuli and highlights the significance of two-component system 
interactions in a human pathogen. 
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Bacterial Two-component Systems 
Bacteria must be able to efficiently sense and respond to their environment, especially 
those that live symbiotically within a host.  The host environment can be harsh for both 
pathogens and commensals alike, and must be equipped to respond to variation in nutrient 
availability, evasion of the immune response, and competition with other bacteria.  Two-
component systems (TCSs) are one of the primary mechanisms that bacteria utilize to 
accomplish this goal.  Over 98 percent of sequenced bacterial genomes contain at least one 
putative TCS (Laub & Goulian, 2007; Stock, Robinson, & Goudreau, 2000).  The number of 
TCSs per genome correlates with the number of environmental niches that a particular bacterial 
species is known to encounter.  For example, Helicobacter pylori, a strict gastric pathogen, 
possess three intact TCSs, while Pseudomonas aeruginosa, which can be colonize and infect a 
multitude of environments from plants to various damaged human tissues, possess an average of 
60 TCSs (MiST Database). In their simplest form, TCSs are comprised of a sensor histidine 
kinase, which detects the changing environment, and a response regulator, which mediates the 
resulting alterations in bacterial behavior to respond to the environmental stressor (Stock et al., 
2000). 
 
Mechanism of signal transduction 
The typical sensor histidine kinase is a membrane embedded protein, located within the lipid 
bilayer of the bacterial cell membrane (Stock et al., 2000).  These proteins canonically possess 
distinct domains: a sensing domain that typically lies extracytoplasmically, at least one 
transmembrane domain that spans the lipid bilayer, as well as a dimerization phosphotransfer 
	 3	
 
 
Figure 1.  Model of classical two-component system autophosphorylation 
The sensor kinase is shown here with the sensing domain (SD) in green, the transmembrane 
domain in blue, the dimerization and phosphotransfer domain (DHp) containing the conserved 
histidine residue in yellow, and the catalytic domain (CA).  The response regulator is shown with 
the receiver domain (RD) containing the conserved aspartate residue in orange, and the DNA 
binding domain (DBD) in pink.  [1] The system is unstimulated where both the sensor kinase and 
the response regulator likely exist as monomers without the presence of signal. [2] The sensor 
kinase detects the presence of signal, inducing dimerization and autophosphorylation at the 
conserved histidine of at least one of the sensor kinase monomers. The front blue arrow depicts 
autophosphorylation in cis, while the back blue arrow depicts autophosphorylation in trans.  
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domain and a catalytic domain, both of which reside in the cytoplasm ((Capra & Laub, 2012; 
Stock et al., 2000) and Fig. 1). Sensor kinases function as dimers, although whether they exist as 
monomers or dimers prior to signal detection remains unclear.  Upon detection of a signal, the  
sensor kinase will hydrolyze ATP to autophosphorylate at a conserved histidine residue within  
the phosphotransfer domain.  This can occur either in cis, where one monomer is using its own 
catalytic domain to hydrolyze ATP to phosphorylate the conserved histidine, or it can occur in 
trans where the ATP catalytic domain of one monomer facilitates the phosphorylation of the 
conserved histidine residue of the second monomer ((Capra & Laub, 2012; Gao & Stock, 2013; 
Stock et al., 2000) and Figure 1). 
The partner, or cognate, response regulator then docks onto an interaction surface within 
the sensor kinase (Capra et al., 2010; Skerker et al., 2008).  Once the kinase and regulator have 
established contact, the regulator catalyzes the transfer of the phosphoryl group from the 
histidine of the sensor kinase to a conserved aspartate on the response regulator ((Capra et al., 
2010; Skerker et al., 2008) and Figure 2).  The interaction surface between the sensor and 
regulator is composed of a series of amino acid residues that allow for specificity between the 
two proteins.  The residues responsible for this stringent molecular recognition are referred to as 
co-evolving residues, because change in one or more residues on the kinase leads to 
compensatory changes in the residues of the response regulator to maintain high affinity 
interactions between the cognate pair and prevent interactions with other TCSs (Capra et al., 
2012; Capra et al., 2010; Skerker et al., 2008) . 
Once phosphorylated, the response regulator dimerizes and assumes a conformation that  
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Figure 2.  Model of classical two-component system phosphotransfer and de-
phosphorylation 
   
[1] The phosphoryl group is then transferred onto the conserved aspartate on the response 
regulator, causing dimerization and activation of that protein. [2] In many cases, sensor kinases 
exhibit phosphatase activity, removing the phosphoryl group from the response regulator, 
thereby allowing for re-sensitization of the system when a new system is detected. 
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allows its output domain to become functional; in most cases, this manifests as DNA binding, 
leading to a change in gene expression (Stock et al., 2000).  Some TCSs are able to auto-regulate 
their own expression, meaning that the response regulator binds the promoter region of the 
operon that encodes the TCS, activating transcription.  In these cases, the TCS transcript levels 
peak around 15 minutes after the bacteria have been exposed to the stimulating signal (Shin, Lee, 
Huang, & Groisman, 2006).  Afterwards, transcript levels decrease as the bacteria respond to the 
stressor, requiring less of the TCS transcript to be made.  This is known as an activation surge 
(Nairismagi et al., 2012; Shin et al., 2006).   
Once the stimulus is no longer detected by the sensor kinase, the system “resets,” so that 
it can appropriately respond to future incoming signals.  To accomplish this, the sensor kinase 
can mediate the removal of the phosphoryl group from the response regulator in one of two 
ways: Either the kinase also exhibits activity or the kinase performs reverse phosphotransfer, 
where the phosphoryl group is transferred from the aspartate within the response regulator back 
to the conserved histidine of the sensor kinase ((Stock et al., 2000) and Figure 2).  
 
Evolution of two-component system fidelity and cross-interactions 
TCSs can be acquired via horizontal gene transfer or from gene duplication events and 
between bacteria.  In the case of gene duplication, the interacting surfaces of the new TCS would 
have significant overlap with the interacting surfaces of the pre-existing TCS, allowing for 
phosphotransfer events to occur between non-cognate pairs (Figure 3).  Therefore, newly 
acquired systems open the opportunity for cross-interactions between TCSs, which can lead to 
response outputs that are not appropriate for the signal that is detected.  Thus, to maintain 
specific interactions between cognate partner proteins, evolutionary pressure selects for co- 
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Figure 3. Evolution of two-component systems. 
As the bacteria acquire new systems, cross-interactions between non-cognate partners acts as an 
intermediary stage during the course of evolution before divergence is achieved.  Box 1 indicates 
two non-interacting two-component systems (red and blue) before the gene duplication event.  
Box 2 indicates the cross-interactions between non-cognate protein pairs after a gene duplication 
event of the blue system, giving rise to the purple TCS. Even as the bacteria detect different 
signals, the outputs are uncontrolled, as the sensor kinases cannot discriminate between response 
regulators. Box 3 indicates the post-divergence state, where each two-component system has 
moved into its own sequence space and cross-interactions have been eliminated.   
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evolving residues on the sensor kinase and response regulator of one TCS pair to diverge from 
those of the pre-existing TCS.  The selection for mutations that maintain specificity between 
cognate partners and the selection against mutations that allow for interactions with non-cognate 
partners is described as the TCS movement through ‘sequence space’ ((Capra & Laub, 2012) and 
Figure 3).   
Intrinsic mechanisms, such as co-evolving residues, maximize specificity within TCSs 
and minimize interactions with other TCSs. However, there have been reports of non-cognate  
interactions between TCS constituents with a beneficial outcome for the bacterium. A handful of 
previous studies have described sensor kinases that are capable of phosphorylating both their 
cognate partner, as well as a non-cognate response regulator in wild-type bacterial cells (Drepper 
et al., 2006; Matsubara, Kitaoka, Takeda, & Mizuno, 2000; Mika & Hengge, 2005; Rabin & 
Stewart, 1993). These examples can be found in multiple bacterial species, including Bacillus 
subtilis (Howell, Dubrac, Noone, Varughese, & Devine, 2006), E. coli (Matsubara et al., 2000), 
and Rhodobacter capsulatus (Drepper et al., 2006). In these examples, cross-regulation between 
TCSs is critical to mediate an appropriate response to environmental stress.  
  Specifically, in R. capsulatus, the interacting NtrBC and NtrXY TCSs have been reported 
to cross-interact in order to mediate nitrogen responses. Bacteria lacking the NtrC response 
regulator, or both NtrY and NtrB sensor kinases cannot properly utilize molecular nitrogen (N2) 
or urea as a nitrogen source. This suggests interactions between non-cognate partners NtrY and 
NtrC are critical in wild-type cells (Drepper et al., 2006). However, the exact signal that initiates 
NtrY - NtrC interactions is unknown. 
In non-pathogenic K12 lineages of E. coli, two interacting TCSs, NarPQ and NarLX 
regulate nitrate metabolism. NarX and NarQ are the sensor kinases, where NarX preferentially 
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senses nitrate, while NarQ senses both nitrate and nitrite.  Both NarQ and NarX are able to 
phosphorylate the response regulators NarL and NarP (Noriega, Lin, Chen, Williams, & Stewart; 
Rabin & Stewart, 1993).  Interestingly, in response to signal, NarQ has a slight kinetic preference 
for the non-cognate NarL, even though it can still phosphorylate its cognate response regulator, 
NarP.  On the other hand, activated NarX maintains strong kinetic preference for the cognate 
NarL, which allows NarX to de-phosphorylate NarL when nitrate is absent (Noriega et al.; Rabin 
& Stewart, 1993; Schröder, Wolin, Cavicchioli, & Gunsalus, 1994). Cross-interactions such as 
these have been proposed to act as a way to fine-tune molecular responses to the multitude of 
signals that bacteria must adapt to in ever changing environments.  However, very little work has 
been performed on this subject, especially in pathogenic bacteria.   
 
Two-component System Signaling in Pathogenesis 
The mammalian host encompasses multiple micro-environments with various stimuli 
bacteria must respond to in order to establish infection.  Therefore, not surprisingly, TCSs have 
been found to be vital for virulence in multiple pathogens.  In Pseudomonas aeruginosa the 
AlgR/FimS TCS controls multiple critical virulence factors, including biofilm formation, 
motility, and the Ysc type III secretion system (T3SS) (Belete, Lu, & Wozniak, 2008; Konyecsni 
& Deretic, 1988; Lizewski, Lundberg, & Schurr, 2002; Morici et al., 2007; Overhage, Lewenza, 
Marr, & Hancock, 2007; Whitchurch, Alm, & Mattick, 1996; Yu, Mudd, Boucher, Schurr, & 
Deretic, 1997).  Although this system is central to signaling required for full virulence, the signal 
that stimulates the system is still unknown.  Not many signals have been identified for TCSs that 
contribute to virulence of a pathogen.  For instance, a deletion of the LisR/LisK, AgrA/AgrC, or 
VirR/VirS TCS in Listeria monocytogenes lead to attenuation; however, there is no known signal 
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for any of these TCSs (Autret, Raynaud, Dubail, Berche, & Charbit, 2003; Cotter, Emerson, 
Gahan, & Hill, 1999; Mandin et al., 2005).  The PmrAB TCS in Salmonella enterica presents a 
rare case where the stimulus has been well characterized (Richards, Strandberg, Conroy, & 
Gunn, 2012; Wosten, Kox, Chamnongpol, Soncini, & Groisman, 2000).  Ferric iron is able to 
stimulate the PmrB sensor kinase, leading to the phosphorylation of the PmrA response 
regulator, which then promotes the expression of genes involved in lipopolysaccharide (LPS) 
modifications (Kato, Chen, Latifi, & Groisman, 2012; Wosten et al., 2000). 
 PmrAB is also unique in that it indirectly interacts with another TCS, PhoPQ. The PhoQ 
sensor kinase is stimulated by low magnesium and cationic polypeptides, leading to PhoP 
phosphorylation, which is important for Salmonella enterica virulence (Bijlsma & Groisman, 
2005; Groisman, 2001).  In Salmonella, PhoP upregulates the expression of pmrD, which 
encodes an accessory protein that interacts with the response regulator PmrA.  This physical 
interaction prevents PmrA from being dephosphorylated by its cognate sensor kinase PmrB and 
locks the PmrAB system in an activated state (Kato & Groisman, 2004). PmrD is negatively 
regulated by PmrAB, closing this regulatory circuit and preventing over-activation of the system 
(Guckes et al., 2013; Kato & Groisman, 2004).  Notably, this interaction between the PhoPQ and 
PmrAB TCSs does not involve cross-phosphorylation between non-cognate sensors and 
regulators.   
The QseBC TCS has been shown to be important to the pathogenesis of multiple bacterial 
species including various E. coli pathotypes, Salmonella enterica, and Francisella tularensis 
(Bearson & Bearson, 2008; Bearson, Bearson, Lee, & Brunelle, 2010; Clarke, Hughes, Zhu, 
Boedeker, & Sperandio, 2006; Kostakioti, Hadjifrangiskou, Pinkner, & Hultgren, 2009; Rasko et 
al., 2008).  In all of these pathogens, deletion of qseC leades to severe virulence attenuation in 
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animal models of infection (Bearson & Bearson, 2008; Bearson et al., 2010; Clarke et al., 2006; 
Rasko et al., 2008).  However, the mechanism of QseBC TCS signaling has been reported 
differently for two different E. coli pathotypes (Clarke et al., 2006; Clarke & Sperandio, 2005; 
Sperandio, Torres, Jarvis, Nataro, & Kaper, 2003).  One hypothesis for this discrepancy is that 
the bacteria have evolved different signal transduction pathways driven by the different selection 
pressures found in distinct niches occupied by enterohemorrhagic E. coli (EHEC) and 
uropathogenic E. coli (UPEC) during pathogenesis. 
 
QseBC signaling in EHEC and UPEC 
EHEC is an enteric pathogen that causes bloody diarrhea and hemolytic-uremic 
syndrome (HUS), which can lead to life-threatening kidney failure due to the destruction of red 
blood cells (Stahl et al., 2015).  The bacteria are typically transmitted from fecal-oral 
contamination (Nguyen & Sperandio, 2012).  Once introduced to the host, EHEC must overcome 
obstacles including destructive enzymes in saliva, acid stress in the stomach, and bile salts in the 
small intestine (House et al., 2009; Nguyen & Sperandio, 2012).  Upon entrance into the large 
intestine, the bacteria must penetrate the physical mucosal barrier to fully adhere to the intestinal 
epithelium (Nguyen & Sperandio, 2012).  Upregulation of virulence factors such as those 
involved in flagella- mediated motility and attaching and effacing (AE) lesions allow the bacteria 
to successfully infect the host (Nakanishi et al., 2009).  During infection, EHEC produce an 
exotoxin called Shiga toxin, which binds to cells in the gastrointestinal tract and inhibits protein 
synthesis by impairing ribosomes (Pacheco & Sperandio, 2012).  This leads to apoptosis and pro-
inflammatory responses within the gut (Pacheco & Sperandio, 2012).  In addition to the physical 
and biochemical barriers associated with colonizing the mammalian gut, EHEC must also 
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overcome a biological barrier, competing for nutrients and space with commensal bacteria.  The 
quorum sensing E. coli BC TCS was initially proposed to aid EHEC in communicating with 
commensal gut microbiota (Sperandio et al., 2003; Sperandio, Torres, & Kaper, 2002).  
Initial studies led to the hypothesis that EHEC QseBC was used to sense and respond to 
bacterial signals as a means to communicate via quorum signaling (Sperandio et al., 2003; 
Sperandio et al., 2002).  It was also reported that QseC was not sensing the previously 
characterized autoinducer (AI)-2 but in fact sensing a novel molecule, AI-3 (Sperandio et al., 
2003).  However, it was also determined that QseC could respond to the hormones epinephrine 
and norepinephrine which offered a platform for EHEC to potentially communicate host cells to 
coordinate virulence factor expression (Sperandio et al., 2003; Sperandio et al., 2002).  EHEC 
QseC was reported to enhance phosphotransfer to cognate response regulator QseB in the 
presence of epinephrine (Clarke et al., 2006).  QseC was proposed to bind epinephrine as a direct 
ligand, although biochemical evidence supporting this hypothesis is lacking (Clarke et al., 2006). 
Early reports concluded that because the deletion of the qseC caused a decrease in motility and 
the expression of flagellin, QseBC is a positive regulator of motility (Sperandio et al., 2002).  As 
a result it was proposed that QseB is a classical TCS in which loss of the sensor kinase leads to 
the inability to activate the response regulator.  
UPEC is the main causative agent of one of the most common bacterial infections: 
urinary tract infections (UTIs) (Hooton & Stamm, 1997). UTIs manifest as either infection of the 
bladder, cystitis, or of the kidneys, pyelonephritis (Foxman, 2010). They are among the most 
common primary diagnosis for female emergency visits and are responsible for roughly 3 billion 
dollars in healthcare costs per year in the US alone (Foxman, 2010).  Outside the hospital setting, 
UTIs disproportionately affect women, with about 50% having at least one UTI during their 
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lifetime.  Among these women who contract a UTI, about 24% will experience a second episode 
within 6 months of the first (Foxman, 2014).  
The gut acts as a reservoir for UPEC, where the bacteria colonize but do not 
symptomatically infect the host (Moreno et al., 2008). Upon exit from the gut, the bacteria 
ascend the urethra and enter the bladder.  To establish bladder infection, the bacteria must 
overcome the primary host defense against UTI, urination (Foxman, 2010). To prevent expulsion 
from the urinary tract, UPEC have evolved a multitude of strategies, including the expression of 
adhesive organelles that allow the bacterial cells to adhere to the bladder epithelium (Foxman, 
2014; Mulvey et al., 1998). This initial adhesion step is crucial to UPEC pathogenesis and 
triggers the bacteria to become internalized by the superficial umbrella cells of the bladder 
(Bower, Eto, & Mulvey, 2005).  Once inside the epithelial cell, UPEC are able to escape into the 
cytoplasm where they are able to replicate to form clonal populations of aggregated bacteria 
known as intracellular bacterial communities (IBCs) (Anderson et al., 2003; Justice et al., 2004).   
IBCs offer the bacteria a mechanism by which to evade host immune responses and stresses from 
antibiotic exposure (Anderson et al., 2003; Hannan, Mysorekar, Hung, Isaacson-Schmid, & 
Hultgren, 2010). The IBC matures and grows in size, until it erupts and filamentous bacteria are 
able to escape from the bladder cell.  Using flagella-based motility, the bacteria either infect 
other bladder epithelial cells or ascend to the kidney (Wright, Seed, & Hultgren, 2005).   
Similar to studies in EHEC, work focusing on UPEC QseC demonstrated that the loss of 
the sensor QseC leads to severe attenuation of UPEC in murine models of acute and chronic UTI 
(Hadjifrangiskou et al., 2012; Kostakioti et al., 2009). However, a detailed genetic analysis 
revealed that UPEC mutants lacking the QseB response regulator or the entire QseBC TCS are 
not defective in the acute infection stages (Kostakioti et al., 2009). In UPEC, deletion of qseC 
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also resulted in low motility compared to WT, but deletion in qseB or the entire qseBC operon 
had no effect on motility (Kostakioti et al., 2009).  It was shown that in UPEC, a deletion in qseC 
led to an accumulation of phosphorylated QseB, which leads to a down regulation of flagella 
expression and motility (Hadjifrangiskou et al., 2011; Kostakioti et al., 2009).  This contradicts 
what has been reported in EHEC, making QseB a repressor of motility in UPEC (Kostakioti et 
al., 2009; Sperandio et al., 2002). Another intriguing observation was the accumulation of 
phosphorylated QseB in the absence of qseC, suggesting that QseB can be activated by a moiety 
other than its cognate sensor kinase (Hadjifrangiskou et al., 2011; Kostakioti et al., 2009). 
 
Unanswered questions in two-component system biology  
The differences reported in the QseBC TCS signal transduction between UPEC and 
EHEC provide a platform for investigating questions widely relevant to TCS biology.  One such 
question being how bacteria are able to utilize TCS cross-interactions to fine-tune responses to 
relevant environmental stimuli.  Given the divergent phenotypes observed with QseB and QseC 
cognate partners, we hypothesized that in the absence of QseC, something else activates QseB.  
Chapter II describes an additional sensor kinase, PmrB, that is able to phosphorylate QseB, 
defining the molecular mechanism of cross-interactions between two TCSs in UPEC (Guckes et 
al., 2013).   
Often, the signals that TCSs respond to are difficult to identify, making it extremely 
difficult to investigate the relevance of a particular TCS to bacterial fitness or virulence in the 
case of pathogens.  Chapter III describes QseBC and PmrAB cross-interactions and 
corresponding phenotypic output in the form of antibiotic tolerance in response to the stimulating 
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signal ferric iron.  Control of the most upstream gene target, qseBC, as well as the conservation 
of this promoter region is described in Chapter IV. 
The differences between UPEC and EHEC are much greater than simply the QseBC 
signals and downstream gene regulation.  These bacteria occupy different niches in the host, and 
therefore have different pathogenic strategies during infection.  Thus it is possible that 
evolutionary pressure is responsible for the divergence in signaling mechanisms.  Chapter IV 
outlines sequence variants in qseBC regulatory regions, which group to the different E. coli 
pathotypes, supporting this hypothesis.  For additional insight as to the physiological relevance 
of ferric iron responses that are specific to UPEC, we began to investigate the UTI89 global 
regulon in response to ferric iron, which is described in Chapter V.
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CHAPTER II 
 
STRONG CROSS-SYSTEM INTERACTIONS DRIVE THE ACTIVATION OF THE QSEB 
RESPONSE REGULATOR IN THE ABSENCE OF ITS COGNATE SENSOR 
 
A portion of this work has been published in the “Proceedings of the National Academy of the 
Sciences” journal as Guckes KR*, Kostakioti M*, Breland EJ, Gu AP, Shaffer CL, Martinez CR 
3rd, Hultgren SJ, Hadjifrangiskou M. 2013 Oct 8;110(41):16592-16597.  
PMID: 24062463 
*Both authors contributed equally to this work 
 
Introduction 
As UPEC infect the urinary tract, the bacteria perform a complex pathogenic cascade, 
which requires elegant detection of and response to both extracellular and intracellular cues to 
accomplish.  Prior to this work, it had been reported that deletion of the sensor kinase qseC in 
UPEC leads to misregulation of gene expression and/or virulence attenuation (Hadjifrangiskou et 
al., 2011; Kostakioti et al., 2009).  The ΔqseC-related defects in UPEC are a result of increased 
activity of the QseB response regulator, which results in increased qseB expression, 
misregulation of conserved metabolic pathways and downregulation of virulence-associated 
genes (Hadjifrangiskou et al., 2011; Kostakioti et al., 2009). Therefore, presumably, qseC 
deletion interferes with QseB de-phosphorylation; however, the source of QseB activation in the 
absence of its cognate sensor QseC was undefined. In the data outlined in this chapter, we 
	 17	
present evidence that UPEC QseB becomes phosphorylated, by a non-cognate sensor histidine 
kinase, PmrB.  
 
Methods 
Strains and constructs  
Experiments here were performed in E. coli cystitis isolate UTI89 and isogenic 
derivatives. UTI89ΔqseC, UTI89ΔqseB and UTI89ΔqseBC were created previously (Kostakioti 
et al., 2009). UTI89ΔqseCΔpmrB, UTI89ΔqseCΔpmrA and UTI89ΔpmrA were created 
following the recombineering method of Murphy & Campellone using λ Red recombinase 
(Murphy & Campellone, 2003). pPmrB was created using vector pTrc99A (Invitrogen) as a 
backbone and inserting the pmrB (UTI89_C4706) coding sequence downstream of its native 
promoter. To create pPmrB_H155A, site-directed mutagenesis was performed on pPmrB, using 
Pfu Ultra DNA polymerase (Stratagene). Tagged constructs pPmrB-mycHis and pPmrB_H155A-
mycHis were created by amplifying the pmrB gene from pPmrB or pPmrB_H155A, and 
subsequently cloned into backbone vector pBADmyc-HisA (Invitrogen).  Constructs pQseC, 
pQseC-mycHis, and the transcriptional reporter plasmid pPqse::GFP were previously constructed 
(Kostakioti et al., 2009).  
 
Transposon mutatgenesis, suppressor screening, and Congo red uptake assays 
Electro-competent UTI89ΔqseC cells and transposon mutagenesis were performed as 
previously described (Hadjifrangiskou et al., 2012).  Briefly, 260ng of the EZ-Tn5™ 
<R6Kγori/KAN-2>Tnp Transposome™ (Epicentre) was electroporated in 100 µl of 
UTI89ΔqseC electro-competent cells, followed by a 60 minute recovery in SOC media at 37°C. 
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The entire transposition reaction was diluted 1 : 10,000 and spread on LB – Kanamycin plates in 
100 µl  aliquots.  
Kanamycin resistant transposants were patch-plated on YESCA (1 g yeast extract, 10 g 
casamino acids, 20 g agar/L) agar supplemented with Congo red (CR), and incubated at 30°C for 
48h. Each YESCA-CR plate included streaks of WT UTI89 and UTI89ΔqseC as positive and 
negative controls.  UTI89 appears red on Yesca-CR, while UTI89ΔqseC appears white. 
 
Transposition Mapping 
UTI89ΔqseC transposon mutants that displayed a red (WT) phenotype on Yesca-CR 
media were treated for DNA isolation and subsequent transposon mapping using the multiple-
round PCR procedure of Ducey and Dyer (Anriany, Sahu, Wessels, McCann, & Joseph, 2006; 
Ducey, Carson, Orvis, Stintzi, & Dyer, 2005) and primers Inv-1 (ATGGCTCA-
TAACACCCCTTGTATTA) or Inv-2 (GAACTTTTGCTGAGTTGAAGGATCA). Resulting 
amplicons were purified (Qiagen) and sequenced using the KAN-2 FP-1 Forward and KAN-2 
RP-1 Reverse primers supplied by Epicentre. 
  
Immunoblots, HA and phase assays 
For type 1 pili, bacteria were incubated in LB media at 37˚C for 4h under shaking 
conditions, sub-cultured (1:1000) in fresh LB media and incubated statically at 37˚C for 18h. 
Immunoblots (using anti-type 1 pili), HA and phase assays were performed on normalized cells 
(OD600=1) as previously described (Kostakioti et al., 2009) with the exception of the FimA 
western blot in Fig. 5A; in this blot, the secondary antibody used was Alexa Fluor 680 donkey 
anti-rabbit IgG (Life Technologies), diluted 1:10,000 in Odyssey blocking buffer (Li-Cor 
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Biosciences) with 0.1% Tween-20, and applied for 30 minutes. Blot was then imaged on an 
Odyssey infrared imaging system (Li-Cor Biosciences) in the 700 nm channel.  
 
Motility assays 
Motility assays were performed as previously described (Wright et al., 2005). Briefly, 
bacteria were inoculated in LB and incubated statically at 37°C for 18 h. Bacteria from the 
overnight culture were stabbed in the center of 0.25% LB agar/0.001% 2,3,5-
triphenyltetrazolium chloride using a sterile inoculating rod and allowed to swim outwards from 
the inoculation point for 7 h at 37°C. Motility diameters were recorded for 5 biological replicates 
with triplicate plates/strain per experiment. 
 
RNA extraction and qPCR 
Total RNA was isolated from E. coli UTI89 and isogenic mutants.  Cells were broken 
open by enzymatic lysis using TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8.0) containing 1 
mg/ml lysozyme. RNA was extracted using the RNeasy kit (Qiagen) and DNase-treated using 
Turbo DNase I (Ambion). First strand cDNA synthesis was performed using 1µg DNAse treated 
RNA and the Superscript II Reverse Transcriptase kit (Invitrogen) following the manufacturer’s 
protocol. For qseB qPCR: WT UTI89, UTI89∆qseC and UTI89∆qseC∆pmrB cDNA was 
generated from RNA samples of cells grown statically at 37°C for 18h in LB. Serial cDNA 
dilutions (25, 12.5, 6.25, 3.125 and 1.5625 ng/µl) were used for qPCR, with qseB- and rrsH-
specific primers (Kostakioti et al., 2009) according to the manufacturer’s instructions (BioRad). 
Relative fold difference was determined by the ∆∆Ct method (Pfaffl, 2001). Experiment was 
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repeated with five separately obtained biological replicates with triplicate reactions/cDNA 
dilution. 
For gfp qPCR, samples for RNA extraction and reverse transcription were obtained from 
cells grown statically at 37°C for 18 h in N-minimal media (0.1% casamino acids, 38 mM 
glycerol, 22 mM glucose, and 10 µM MgCl2, pH 7.7) with and without 100 mM FeCl3. 
Quantitative real time PCR was executed in triplicate on an ABI StepOne Plus Real Time PCR 
machine, using multiplexed TaqMan MGB chemistry.  Two dilutions of cDNA (25 ng and 6.25 
ng) were analyzed per isolate for each experimental condition. Abundance of gfp transcripts 
(probe: 5’6FAM-ACGTGCTGAAGTCAAG3’) in UTI89 isogenic mutant strains was calculated 
using the ΔΔCT method, with each transcript signal normalized to the abundance of the rrsH 
(probe: 5’VIC-CGTTAATCGGAATTACTG3’) internal control and comparison to the 
normalized transcript levels of WT UTI89. Abundance of pmrB transcripts (probe: 5’6FAM-
ACGCCCATTGCCA) was calculated as above, but normalized to the abundance of the gyrB 
internal control (probe: 5’VIC-ACGAACTGCTGGCGGA). As a control, DNAse-treated RNA 
samples not subjected to reverse transcription were analyzed by qPCR in parallel. 
 
Mouse infections 
Female C3H/HeN mice (Harlan), 7–9 weeks old, were transurethrally infected with 107 
bacteria carrying the plasmid pANT4 as previously described (Kostakioti et al., 2009). IBC 
enumeration was performed using confocal microscopy as described by Kostakioti et al. 
Experiments were repeated three times and statistically analyzed using two-tailed Mann-Whitney 
(P<0.05, considered significant).  
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Microscopy 
For fluorescence microscopy, bacteria were grown without shaking, in modified N-
minimal media (5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 1 mM KH2PO4, 0.1 mM Tris-
HCl pH 7.4, 10 mM or 10 mM MgCl2, 0.2% glucose, 0.1% Casamino acids, 38 mM glycerol /L) 
pH 7.6 and visualized using a Zeiss fluorescence microscope. 
 
PmrA and QseB purification 
  The pQseB-mycHis construct used for QseB expression and purification was previously 
constructed (Kostakioti et al., 2009). The pPmrA-mycHis was constructed for this study by 
amplifying the pmrA gene and cloning into the pBAD-mycHisA vector. Protein expression was 
induced with 0.1% arabinose and the proteins were affinity-purified using a Talon column 
(Clontech), followed by anion exchange chromatography through a MonoQ column (GE 
Healthcare), as described in (Kostakioti et al., 2009). 
 
Electrophoretic mobility shift assays 
Purified QseB and PmrA was incubated with DNA fragments in binding buffer (final 
concentration: 20mM Tris-HCl, 5mM MgCl2, 5mM KCl, 10% glycerol) for 20 minutes at room 
temperature. Reactions were loaded onto a 5% acrylamide non-denaturing gel. Electrophoresis 
was performed for 2.5 hours at 50V.  Gels were dried at 80°C for 2 hours before being exposed 
to X-ray film at -80°C. 
 
Preparation of QseC- and PmrB-enriched membranes 
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UTI89ΔqseCΔpmrB/pPmrB-mycHis, UTI89ΔqseCΔpmrB/pPmrB_H155A-mycHis, 
UTI89ΔqseC/pQseC-mycHis and UTI89ΔqseCΔpmrB/pBAD-mycHisA were grown to an OD600 
= 0.6, in LB with shaking at 37°C and induced with 0.02% arabinose for 2 h. Cells were 
mechanically lysed by French Press (1000 p.s.i) and total membranes were isolated by 1 h ultra-
centrifugation at 15,000 r.p.m., and re-suspended in 20 mM Tris (pH 8.0)/1 mM MgCl2. 
 
Phosphotransfer and phosphatase assays 
Membranes from UTI89ΔqseC/pQseCmyc-His or UTI89ΔqseC/pBADmyc-HisA (7 µg) 
were incubated in the absence or presence of purified QseB (14 µg) with 0.7 mCi [γ-32P]-ATP, in 
1x TBS/0.5 mM DTT/0.5 mM MgCl2 per reaction. A 10-reaction master-mix was prepared and 
10 µl aliquots were removed at different time points, mixed with SDS loading buffer and kept on 
ice until SDS-PAGE. For the phosphatase assays, beads were prepared and used to in vitro 
phosphorylate QseB according to (Kato & Groisman, 2004).  QseB~P (0.2 nmol, equal to 9,000 
c.p.m) was incubated at room temperature with 7 µg of membrane vesicles in 1x TBS/0.5 mM 
DTT/0.5 mM MgCl2. Aliquots (10 µl) were withdrawn from the reaction master-mix and treated 
as described above. Gels were dried and exposed to X-ray film for 48h at -80°C. Band intensities 
corresponding to QseB~P over time were quantified using ImageJ software and normalized to 
QseB~P at time=0. All experiments were repeated at least 3 times with biological replicates. 
 
Results 
Transposon mutagenesis identifies suppressors of the qseC deletion 
To identify the primary QseB activating source, we performed a suppressor screen using 
a library of UTI89ΔqseC transposon mutants and a phenotypic assay that assesses curli 
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production based on colony morphology. Deletion of qseC downregulates expression of curli 
adhesive fibers; thus, when grown on Yeast Extract-Casamino Acids (YESCA) agar, 
supplemented with the Congo Red dye (CR), UTI89ΔqseC forms white and smooth colonies 
indicative of diminished curli production, in contrast to WT UTI89 which exhibits a red, dry and 
rough morphotype (Kostakioti et al., 2009). Screening a UTI89ΔqseC transposon library on 
YESCA-CR agar, identified 37 suppressor mutants with WT- or near-WT morphology. 
Subsequent transposition mapping of the mutants with WT morphology identified 7 unique 
genes (Fig. 4A). Among those, qseB served as a robust internal control, since we have previously 
shown that UTI89ΔqseBC produces WT levels of curli (Kostakioti et al., 2009). The other 
identified targets included the PmrB (also known as BasS) sensor kinase, the SdiA regulatory 
protein, the cold-shock DEAD box protein A, the hypothetical YfiR protein, as well as FadD and 
CyoA, involved in respiration (Fig. 4A).  
The identified disruptions may restore curli expression by affecting the activation state of 
QseB, or by impacting regulation of curli gene expression in a QseB-independent manner. We 
have previously shown that UTI89ΔqseC is non-motile and exhibits reduced type 1 pili 
expression (Hadjifrangiskou et al., 2011; Kostakioti et al., 2009). Given that disruption of the 
true QseB phospho-donor should suppress all ΔqseC-related defects, we also tested for 
restoration of motility and type 1 pili expression in each of the identified transposon mutants. 
Western blot analysis probing for the major type 1 pili subunit FimA, and motility assays 
revealed that only disruption of either qseB, or pmrB fully restored UTI89ΔqseC FimA 
expression and motility to WT levels (Fig. 4B-C, respectively). Based on these observations, we 
further investigated the potential contribution of PmrB to QseB activation.  
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Disruption of pmrB in the absence of qseC suppresses the ΔqseC phenotypes 
We generated a clean pmrB deletion in the UTI89ΔqseC strain background to verify that 
the effects we saw with Tn::pmrB were specific to pmrB disruption and not an artifact of 
transposition. Indeed, the resulting mutant, UTI89ΔqseCΔpmrB, behaved like the corresponding 
transposon mutant, being restored for motility, curli and type 1 pili expression (Fig. 5A). 
Subsequent qPCR analysis showed that qseB transcript levels in UTI89ΔqseCΔpmrB were 
similar to WT UTI89, indicating that disruption of pmrB abrogates the increased qseB 
transcription observed in UTI89ΔqseC (Fig 5B). These phenotypes are specific to pmrB deletion 
as complementation of UTI89ΔqseCΔpmrB with PmrB under its native promoter (plasmid 
pPmrB) resulted in a ΔqseC phenotype (Fig 5A).  
UTI89ΔqseC is severely attenuated in vivo, forming considerably fewer IBCs and being 
less fit during acute and chronic infection (Kostakioti et al., 2012; Kostakioti et al., 2009).  Given  
that deletion of pmrB restored type 1 pili expression, we tested the ability of UTI89ΔqseCΔpmrB 
to establish acute UTI. Female C3H/HeN mice were transurethrally inoculated with 107 UTI89, 
UTI89ΔqseC or UTI89ΔqseCΔpmrB.  Bladder colony forming units (CFU) and IBC numbers 
were assessed at 6 h post infection (h.p.i), marking the middle of IBC development, and 16 h.p.i, 
marking the end of the first IBC cycle at which time bacteria disperse from the biomass, 
spreading to neighboring cells (Justice et al., 2004). In contrast to UTI89ΔqseC, 
UTI89ΔqseCΔpmrB formed WT-levels of IBCs, and was able to establish acute infection as 
efficiently as WT UTI89 (Fig 5C). Based on these data we further tested the hypothesis that 
PmrB is the primary QseB phospho-donor in the absence of QseC and that its deletion abrogates 
QseB-mediated gene dysregulation.  
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Figure 4. Random mutagenesis screening identifies suppressors of the qseC deletion 
phenotype  
 
A) Table depicting factors the disruption of which restored wild-type (WT) curli morphology in 
the qseC deletion mutant. Transposon mutagenesis was performed as described in 
(Hadjifrangiskou et al., 2012). B) Western blot probing for FimA protein abundance in 
suppressor mutants shown in (A). A representative of 2 experiments is shown. C) Bar graph 
depicting average motility diameters (in mm) of each suppressor mutant compared to WT UTI89 
and UTI89ΔqseC after 7h of groWTh in soft LB-agar (0.25%). Average motility diameters were 
calculated using data from 3 independent experiments. Statistical analyses were performed using 
unpaired, two-tailed Student’s t-test. *, P≤0.01, ***, P<0.0001. 
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PmrB cannot efficiently de-phosphorylate QseB 
If PmrB phosphorylates QseB in the absence of QseC, then ablating the PmrB kinase activity by 
site-directed mutagenesis should yield the same outcome as the pmrB deletion. We thus altered 
the PmrB phospho-accepting histidine (H155) to alanine. The resulting construct, 
pPmrB_H155A, was introduced to UTI89ΔqseCΔpmrB and the generated strain 
UTI89ΔqseCΔpmrB/pPmrB_H155A was tested for motility. Motility assays indicated that in 
contrast to the non-motile UTI89ΔqseCΔpmrB/pPmrB (Fig. 5A and 6A), 
UTI89ΔqseCΔpmrB/pPmrB_H155A exhibited WT motility (Fig 6A), indicating that the kinase 
activity of PmrB is linked to QseB activation. Subsequent in vitro phosphotransfer assays 
confirmed that PmrB phosphorylates QseB (Fig. 6B). For these assays, membrane vesicles (MV) 
were generated from UTI89ΔqseCΔpmrB/pPmrB_mycHisA (PmrB-enriched MV), 
UTI89ΔqseCΔpmrB/p-BAD_mycHisA (MV lacking PmrB), or UTI89ΔqseC/pQseC_mycHis  
(QseC-enriched MV) as described in materials and methods. We observed that phosphorylation 
of purified QseB occurred upon 15 min incubation with PmrB-enriched MV (Fig. 6B, left panel), 
but not upon incubation with MV lacking PmrB (Fig. 6B, right panel).  PmrB-enriched vesicles 
incubated in the absence of QseB (Fig. 6B, middle panel), were used as a control for PmrB auto-
kinase activity.  
Given that QseB~P requires the QseC phosphatase activity for de-phosphorylation and 
de-activation (Kostakioti et al., 2009), we tested the hypothesis that PmrB cannot de-
phosphorylate QseB as efficiently as QseC. We performed a time-course, assessing de-
phosphorylation of in vitro-phosphorylated QseB (QseB~P) incubated with PmrB-enriched MV, 
MV lacking PmrB or QseC-enriched MV. Using ImageJ analysis, we determined that, after 5 
minutes of incubation 25% of QseB was de-phosphorylated by PmrB. After 60 minutes of 
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Figure 5. Deletion of pmrB in UTI89DqseC restores in vitro and in vivo phenotypes  
A) Motility and FimA Western blot assays demonstrating that UTI89ΔqseCΔpmrB exhibits WT 
motility and expresses WT-levels of type 1 pili. Both phenotypes are suppressed upon 
complementation with pmrB. B) Relative-fold change of qseB in WT UTI89, UTI89ΔqseC, 
UTI89ΔqseCΔpmrB, measured by qPCR. Values are normalized to the rrsH gene. An average of 
3 independent experiments is shown; error bars represent SEM. C) Graphs showing bladder titers 
and IBC numbers recovered at 6 and 16 h.p.i. for WT UTI89, UTI89ΔqseC and 
UTI89ΔqseCΔpmrB. *, P P≤0.027; **, P≤0.0024, determined by two-tailed Mann-Whitney.  
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incubation 60% of QseB remained phosphorylated (Fig. 6C. left panel). In striking contrast, 44% 
of QseB was de-phosphorylated after 5 minutes of incubation in the presence of QseC, and by 60 
min of incubation, only 2.5% of QseB~P remained phosphorylated (Fig. 6D). Incubation of 
QseB~P with MV lacking PmrB or QseC or incubation of QseB in the absence of MV altogether 
did not significantly impact the QseB phosphorylation state (Fig. 6C, middle and right panels), 
indicating that QseB~P does not get de-phosphorylated by other kinases/phosphatases in the MV 
and it does not undergo significant spontaneous de-phosphorylation. These findings demonstrate 
that, remarkably, PmrB exhibits phosphatase activity towards QseB~P, but de-phosphorylation 
occurs considerably slower than with QseC. Collectively, our data show that although PmrB can 
phosphorylate QseB at rates relatively comparable to QseC, it is significantly less efficient in its 
ability to dephosphorylate QseB~P, resulting in the disproportionate activation of QseB in the 
qseC mutant.  
 
The PmrA response regulator contributes to qseBC induction in the absence of QseC 
Given the involvement of PmrB in activating UPEC QseB at the protein level, we 
wondered whether the PmrB cognate response regulator, PmrA, is involved in the observed 
qseBC induction in the ΔqseC mutant. Scanning the qseBC promoter region for the PmrA 
binding sequence (5’-(C/T)TTAA(G/T)-N5-(C/T)TTAA(G/T)-3’) (Kato, Latifi, & Groisman, 
2003; Tamayo, Prouty, & Gunn, 2005; Wosten & Groisman, 1999), revealed the presence of a 
PmrA binding consensus (Fig. 7A) overlapping the previously reported QseB-dependent 
promoter (Clarke & Sperandio, 2005).   
Therefore, we investigated the hypothesis that, in addition to PmrB activating QseB at the 
protein level (via phosphorylation), PmrA is involved in mediating qseBC transcription. We used 
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Figure 6. PmrB phosphorylates QseB in the absence of QseC  
A) Effects of inactivating PmrB kinase activity on the motility of UTI89ΔqseCΔpmrB/pPmrB, 
UTI89ΔqseCΔpmrB and UTI89ΔqseCΔpmrB/pPmrB_H155A. Motility diameters were 
measured after a 7h of incubation at 37°C. B) Phosphotransfer assays with PmrB-enriched 
membrane vesicles (MV) and purified QseB. Middle panel demonstrates PmrB autokinase 
activity in the absence of QseB. The last panel depicts a mock phosphotransfer assay using MV 
without PmrB to verify that phosphotransfer to QseB occurs specifically by PmrB. A 
representative of 3 independent experiments is shown. C-D) In vitro phosphatase assays with 
PmrB-enriched membrane vesicles (MV) and in vitro phosphorylated QseB~P. Percent QseB~P 
was calculated based on peak intensity analysis of each band normalized to the sample at t=0, 
using the ImageJ software. A representative of 3 independent experiments is shown.   
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a previously constructed qseBC promoter-GFP reporter plasmid, Pqse::GFP (Kostakioti et al., 
2009) in combination with qPCR to assess the contribution of PmrA on promoter activity. We 
had previously shown that, although Pqse::GFP was robustly active in UTI89ΔqseC, there was 
no promoter activity recorded in WT UTI89 or UTI89ΔqseBC during growth in either LB or N-
minimal media (Kostakioti et al., 2009). Here, we constructed a non-polar pmrA deletion in 
UTI89 and UTI89ΔqseC, introduced Pqse::GFP in the resulting mutants and sampled gfp steady-
state transcript and GFP fluorescence as a proxy to qseBC expression. This allowed us to assess 
qseBC promoter activity in a panel of mutants, including those lacking qseB (in which a qseB-
specific probe would not be informative). Consistent with our above observations, qseBC 
expression in UTI89ΔqseCΔpmrB was similar to WT UTI89 and UTI89ΔqseBC and was 
significantly lower than UTI89ΔqseC (Fig. 7B and Fig. 8). However, deletion of pmrA in the 
absence of QseC (UTI89ΔqseCΔpmrA) resulted in a 2-fold reduction of gfp steady-state 
transcript (Fig. 7B and Fig. 8), indicating that PmrA contributes to qseBC transcription. Previous 
studies showed and PmrA induces pmrAB expression in response to ferric iron (Wosten et al., 
2000). Despite the absence of the PmrAB activating signal, it is possible that deletion of pmrA 
affects transcription of pmrB, resulting in less PmrB protein, which would impact levels of 
phosphorylated QseB. To test this hypothesis, we sampled pmrB expression in the absence of 
pmrA using qPCR, and found that pmrB levels in fact increased in the pmrA mutants under the 
tested conditions (Fig. 7C). Therefore, the observed reduction in qseBC transcript in 
UTI89ΔqseCΔpmrA is not the result of lower PmrB and QseB~P levels, but rather a result of the 
PmrA absence.  
We therefore tested if PmrA directly binds to the qseBC promoter using electrophoretic 
mobility shift assays (EMSAs).  As a positive control, we tested PmrA binding to the yibD 
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Figure 7. PmrA contributes to qseBC upregulation in the absence of QseC  
A) The qseBC promoter region from UTI89 (spanning nt 3387071-3387110) harbors a PmrA 
binding consensus that precedes the previously described (Clarke et al., 2005) QseB-dependent 
start site. B) Relative-fold change of gfp driven by the qseBC promoter in WT UTI89, 
UTI89ΔqseC, UTI89ΔqseBC, UTI89ΔqseCΔpmrA, UTI89ΔqseCΔpmrB, UTI89ΔpmrA and 
UTI89ΔpmrB measured by qRT-PCR. C) Relative-fold change of pmrB in WT UTI89, 
UTI89ΔqseC, UTI89ΔqseBC, UTI89ΔqseCΔpmrA, UTI89ΔqseCΔpmrB, UTI89ΔpmrA, 
UTI89ΔpmrB and UTI89ΔqseBΔpmrA measured by qPCR.  Quantitative real time PCR was 
executed in triplicate on an ABI StepOne Plus Real Time PCR machine, using multiplexed 
TaqMan MGB chemistry.  Two dilutions of cDNA (25 ng and 6.25 ng) were analyzed per 
isolate. Abundance of gfp transcripts (probe: 5’6FAM-ACGTGCTGAAGTCAAG3’) in UTI89 
isogenic mutant strains was calculated using the ΔΔCT method, with each transcript signal 
normalized to the abundance of the rrsH internal control (probe: 5’VIC-
CGTTAATCGGAATTACTG3’) and comparison to the normalized transcript levels of 
WT UTI89. Abundance of pmrB transcripts (probe: 5’6FAM-ACGCCCATTGCCA) was 
calculated as above, but normalized to the abundance of the gyrB internal control (probe: 5’VIC-
ACGAACTGCTGGCGGA). Error bars for both graphs represent SEM. Statistical analyses were 
performed by two-tailed unpaired t-test, where *, P<0.03; **, P≤0.0053.  
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Figure 8. QseBC upregulation in the absence of QseC involves both PmrB and PmrA  
A-C) Fluorescence microscopy, tracking qseBC promoter-driven GFP expression. Duplicate 
slides per strain were scanned for fluorescence per experiment. Data shown are representative of 
three independent experiments. Images shown are representative of the bacterial populations 
sampled per slide. 
 
 
 
 
	 34	
 
 
Figure 9. PmrA directly binds to the qseBC promoter  
A) Electrophoretic mobility shift assays (EMSAs) with purified PmrA and 32P end-labeled 
qseBC promoter fragment.  The internal region of pmrB was amplified and used as a negative 
control for PmrA binding, while the previously identified yibD promoter (Tomayo et. al., 2002) 
was used as a positive control for PmrA binding. B) EMSA using 30 pmol purified PmrA and 
indicated ratios of qseBC promoter as 32P end-labeled: unlabeled.  
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Figure 10. Deletion of pmrA abolishes some of the qseC deletion defects  
A) FimA Western blot probing total cell lysates from a panel of qse/pmr mutants. Blot was 
imaged on an Odyssey infrared imaging system (Li-Cor Biosciences, Lincoln, NE) in the 700 nm 
channel. B) Motility phenotypes of the qse/pmr mutants; bacteria were inoculated into 0.25% LB 
agar/0.001% 2,3,5-triphenyltetrazolium chloride and incubated at 37°C for 7 h. Motility 
(depicted in the photo panels for each mutants) was evaluated by measuring the motility 
diameters (presented in the accompanying graph). Experiment was repeated 2 times with 
triplicate plates/strain. ***, P≤0.0001, determined by two-tailed unpaired Student’s t-test. C) 
Yeast Extract/Casamino Acid (YESCA) agar plate supplemented with Congo Red (CR) dye 
serving as a proxy to curli fiber expression. Curli positive bacteria appear bright red on these 
media, while curli-negative bacteria appear white and smooth. Biofilm formation after 48h in 
YESCA media is depicted in the graph on the right hand panel. Quantitation of biomass was 
performed using the colorimetric method of O’Toole as previously described (Hadjifrangiskou et 
al., 2012). Experiment was repeated twice with three technical replicates per biological repeat. *, 
P<0.05, ***, P≤0.0001, as determined by two-tailed unpaired Student’s t-test. Asterisks directly 
above bars depicting significance compared to WT UTI89. 
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promoter, a previously identified direct PmrA target (Tamayo, Ryan, McCoy, & Gunn, 2002).   
Using a previously established protocol with increasing concentrations of PmrA, we detected 
binding to qseBC promoter at concentrations lower than those observed for yibD (Figure 9A).   
Competition assays with unlabeled qseBC promoter DNA titrated PmrA binding from the 32P-
labeled qseBC promoter fragments, validating specificity for this sequence (Figure 9B).  Taken 
together, our findings indicated that in the absence of QseC, qseBC upregulation comes from a 
possible synergistic effect of high levels of activated QseB~P and the activity of PmrA (the 
phosphorylation state of which for this function remains unknown) likely on the qseBC 
promoter.  
Over 500 genes are differentially expressed in the absence of QseC, due to aberrant qseB 
induction (Hadjifrangiskou et al., 2011). The observed 50% reduction in qseBC expression in 
UTI89ΔqseCΔpmrA may be sufficient to abrogate some of the known QseC defective 
phenotypes, and in particular expression of type 1 pili, curli and flagella. As was the case for 
UTI89ΔqseCΔpmrB, UTI89ΔqseCΔpmrA expressed WT-levels of type 1 pili (Fig. 10A), and 
regained motility (Fig. 10B). However, despite the WT-levels of CR uptake, UTI89ΔqseCΔpmrA 
was defective in YESCA biofilm formation, compared to WT UTI89 and UTI89ΔqseCΔpmrB 
(Fig. 10C), suggesting that deletion of pmrA is not sufficient to suppress all of the ΔqseC 
phenotypes. Thus, PmrA and QseB contribute to qseBC upregulation in the absence of QseC, 
revealing a previously uncharacterized link between PmrAB and QseBC that may be of 
physiological significance.  
 
Discussion 
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Signal integration through TCS is among the means exploited by bacteria to sample 
environmental changes and tailor their gene expression profile in a manner that enables survival 
in a specific condition. Bacterial genomes can harbor multiple TCSs, which regulate most 
aspects of bacterial physiology, spanning chemotaxis, central metabolism, stress responses and 
virulence.  
It was previously reported that in UPEC, the absence of the QseC sensor leads to aberrant 
and robust phosphorylation of the cognate response regulator QseB by a non-cognate sensor or 
phosphor-donor molecule (Kostakioti et al., 2009). This aberrant cross-talk imparts pleiotropic 
gene expression changes that negatively impact bacterial physiology and attenuate virulence 
(Hadjifrangiskou et al., 2011; Kostakioti et al., 2009). The work presented in this chapter 
revealed the identity of the phosphodonor protein responsible for activating QseB in the absence 
of QseC.  Our data indicated that the PmrB sensor kinase, which is canonically paired with the 
PmrA response regulator, can robustly phosphotransfer to QseB. PmrB-mediated 
phosphotransfer event to QseB is kinetically comparable to the phosphotransfer rate between 
QseC and QseB.  This observation lies outside the established paradigm in the field, which states 
that interaction between non-cognate pairs is disfavored and thought to only occur weakly upon 
cognate sensor disruption. 
As discussed in Chapter I, molecular determinants, both sequence and structure-based, 
between sensor kinase and response regulator proteins ensure fidelity between cognate partners 
(Capra & Laub, 2012).  Upon a gene duplication event yielding a new TCS, these molecular 
determinants normally unique between cognate pairs, would be the same between the new and 
old TCSs.  This presents the opportunity for TCSs to cross-interact, potentially preventing the 
bacteria from responding appropriately to specific stimuli.  If this is the case, evolutionary 
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pressure will cause the TCSs to diverge, allowing each system to sense and respond to a specific 
signal by restricting molecular interactions between cognate pairs.  PmrB is the closest homolog 
of QseC in UTI89, with 37% sequence identity and 70% coverage, suggesting that one system 
gave rise to the other by a gene duplication event.  This also suggests that the interacting 
interfaces of PmrB and QseC share common features, or co-evolving residues, that enable 
similar protein-protein interactions with QseB.  Therefore, there are two explanations for the 
robust cross-interactions between QseBC and PmrAB: Either these systems are in the process of 
diverging and we are observing them in the midst of evolution, or there is a physiological reason 
that these systems cross-interact and there is evolutionary pressure to maintain this interaction. 
Our study documents a strong interaction between a RR and a non-cognate sensor: PmrB 
readily phosphorylates QseB, with kinase reaction kinetics similar to those of QseC. PmrB 
phosphatase activity towards QseB is slow, thus providing a potential explanation for the 
observed QseB over-activation when QseC is not present.  Although PmrB phosphatase activity 
is slow towards QseB, the presence of any phosphatase activity between these non-cognate 
proteins is intriguing because phosphatase activity is one of the main mechanisms for preventing 
cross-talk between systems (Alves & Savageau, 2003).  This provides further evidence to 
suggest a physiological link between the QseBC and PmrAB TCSs.   
In addition to identifying PmrB and investigating its phosphotransfer kinetics in relation 
to QseC, we have discovered that in the absence of QseC, the PmrB cognate response regulator, 
PmrA contributes to aberrant expression of the qseBC operon, possibly by augmenting qseB gene 
expression. The current analyses have shown that, while the ΔqseCΔpmrB double mutant 
suppresses aberrant qseB expression back to WT levels (Fig. 7B and 7B) deletion of pmrA in 
UTI89ΔqseC only results in a 50% reduction of qseB steady-state transcript (Fig. 7B). These 
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data demonstrate that in addition to cross-talk between PmrB and QseB there is a potential 
synergistic effect of the two RR on qseBC promoter activation. Previous analyses by Clarke et 
al., had mapped QseB-dependent and –independent start sites within the qseBC promoter of the 
EHEC strain 86-24 (Clarke & Sperandio, 2005). Clarke et al. had reported that the QseB-
dependent start site disappears in the qseC deletion mutant, while, a QseB-independent start site 
exists downstream of the QseB-dependent start. Interestingly, the mapped QseB-independent 
transcriptional start reported by this group, is very highly prominent in the qseC deletion mutant 
(Clarke & Sperandio, 2005). It is thus possible that PmrA contributes to transcriptional control 
from this start site in the absence of QseC, augmenting qseB upregulation in the qseC mutant and 
driving the increase in QseB levels.  The involvement of PmrA in the transcriptional control of 
the qseBC operon is further evidence that there is a physiological reason for the cross-
interactions between QseBC and PmrAB, suggesting that these systems may be engaging in 
cross-regulation.  The mechanism of transcriptional control orchestrated by these two response 
regulators is described in chapter IV. 
Collectively, this work demonstrates that the bi-functional nature of sensors is crucial in 
maintaining an optimal ratio of cognate RR phosphorylated and unphosphorylated states to 
prevent aberrant RR activity and fine-tune physiological TCS cross-talk, facilitating proper 
responses to signal.  PmrA involvement in qseBC transcriptional control, coupled with PmrB 
phosphatase activity towards QseB, suggests that cross-interactions between QseBC and PmrAB 
are evolutionarily selected for and may result in beneficial cross-regulation, which is the focus of 
Chapter III.  
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CHAPTER III 
 
PMRA AND QSEB MEDIATE TOLERANCE TO POLYMYXIN B IN UROPATHOGENIC 
ESCHERICHIA COLI 
 
 
 
A portion of this work has been published in the journal “Science Signaling” as K. R. Guckes*, 
E. J. Breland*, E. W. Zhang, S. C. Hanks, N. K. Gill, H. M. S. Algood, J. Schmitz, C. Stratton, 
and M. Hadjifrangiskou. 2016 Jan 10;10(461).		
PMID: 28074004 
*Both authors contributed equally to this work 
 
Introduction 
In Salmonella enterica, PmrAB directs the expression of a regulon that ultimately alters 
LPS composition and confers tolerance or intrinsic resistance to cationic polypeptides, such as 
polymyxin B (PMB) (Kato et al., 2012; Richards et al., 2012; Wosten et al., 2000).  Activation of 
PmrAB in Salmonella occurs via elevated ferric iron (Fe3+), which is directly detected by PmrB, 
or via cationic polypeptides that are detected by the PhoQ sensor of the PhoPQ system.  Previous 
studies in K12 E. coli suggested that indirect stimulation of PmrB by cationic polypeptides does 
not occur, leading to the conclusion that PhoPQ signaling is not implicated in mediating E. coli 
tolerance to PMB (Winfield & Groisman, 2004).   
PMB mimics polymyxin E, otherwise known as colistin, in terms of antibiotic 
mechanism of action, clinical use, and toxicity, and it has become a last resort antibiotic, to treat 
multidrug resistant Enterobacteriaceae (Kwa, Kasiakou, Tam, & Falagas, 2007; Mediavilla et 
al., 2016).  Increase in antibiotic resistance has become a serious issue in the treatment of UTIs.  
	 42	
Carbapenem resistant Enterobacteriaceae (CRE) have become such a serious public health issue 
that the Center for Disease Control elevated these pathogens to an urgent threat level.  Recently 
there was a report of a woman with a UTI that was caused by UPEC that was classified as CRE, 
which was additionally resistant to colistin, via a plasmid, which contains the colistin resistance 
conferring mcr-1 gene (Mediavilla et al., 2016).  This gene is an ortholog to pmrC, one of the 
PmrA target genes that modifies lipid A of the LPS in Salmonella (Chen & Groisman, 2013).   
Data presented in Chapter II suggested a physiological link between the PmrAB and 
QseBC systems, the molecular mechanism and the significance of which remains undetermined. 
We therefore wondered whether QseBC-PmrAB interactins have evolved in E. coli to mediate 
intrinsic tolerance to PMB. 
 Here we present evidence that elevated ferric iron induce PmrB activation, which then 
phosphorylates PmrA and QseB, both of which are required to mediate resistance to PMB. This 
response is different from the PmrAB stimulus response established for Salmonella spp., because 
in UPEC, the PhoPQ TCS plays a minor role in PmrAB activation ((Winfield & Groisman, 2004; 
Wosten et al., 2000) and Fig. 18). Biochemical analyses demonstrated that PmrB kinase activity 
was enhanced toward both its cognate (PmrA) and non-cognate (QseB) response regulators in 
the presence of ferric iron, leading to an activation surge in transcription of the qseBC locus that 
was PmrA/QseB-dependent. QseB and PmrA response regulators were both necessary to mediate 
optimal transcription of downstream target genes in response to ferric iron. These data describe a 
unique example in which activation of a single bacterial receptor (PmrB) leads to the co-opting 
of a non-cognate response regulator (QseB) to elicit a physiologically relevant response.  
 
Methods 
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Bacterial strains and growth conditions  
Cultures were grown in Lysogeny broth (Fisher) or N minimal broth with or without 
ferric iron (Fisher) or epinephrine (Sigma) at 37°C with shaking. UTI89ΔqseC, 
UTI89ΔpmrBΔqseC, and the corresponding, pQseC, pQseC-mycHis, pPmrB, and pQseC-
mycHis plasmid constructs harboring the corresponding wild-type qseC and pmrB gene 
sequences were created previously (Guckes et al., 2013; Kostakioti et al., 2009). Promoter 
activity for the qseBC operon was measured using a previously created qseBC promoter 
transcriptional reporter construct, Pqse::gfp (Guckes et al., 2013; Kostakioti et al., 2009).  
 
Phosphotransfer assays 
Membranes from each strain (7 µg) were incubated with purified QseB (14 µg) and 0.7 
µCi [γ-32P]-ATP, in the absence or presence of signal, with 1x TBS, 0.5 mM DTT, and 0.5 mM 
MgCl2 per reaction. A 7 reaction master-mix was prepared and 10 µl aliquots were removed at 
different time points, mixed in a 1:1 ratio with 2X SDS loading buffer and kept on ice until SDS-
PAGE. Aliquots (10 µl) were withdrawn from the reaction master-mix and treated as described 
above. Gels were dried and exposed to X-ray film for 48 h at -80°C. Band intensities 
corresponding to QseB~P over time were quantified using ImageJ software and normalized to 
QseB~P at time=0. All experiments were repeated 2-4 independent times, with different 
biological samples. 
 
Phosphatase assays 
Beads were prepared and used to in vitro phosphorylate QseB as described in (Kato & 
Groisman, 2004). QseB~P (0.2 nmol) was incubated at room temperature with 7 µg of membrane 
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vesicles, harboring QseC, PmrB, or neither kinase, in the presence or absence of signal in a 
reaction buffer comprising 1x TBS, 0.5 mM DTT, and 0.5 mM MgCl2. Aliquots (10 µl) were 
withdrawn from the reaction master-mix and treated as described above. Gels were dried and 
exposed to X-ray film at -80°C. Band intensities corresponding to QseB~P over time were 
quantified using ImageJ software and normalized to QseB~P at time=0.  
 
QseB and PmrA purification 
  The pQseB-mycHis and pPmrA-mycHis constructs used for QseB and PmrA expression 
respectively and purification was previously constructed (Kostakioti et al., 2009). QseB 
expression was induced with 0.1% arabinose and QseB was affinity-purified using a Talon 
column (Clontech), followed by anion exchange chromatography through a MonoQ column (GE 
Healthcare), as described in (Kostakioti et al., 2009).  
 
Electrophoretic mobility shift assays 
Purified and in vitro phosphorylated response regulators were incubated with 105bp 
fragment of the yibD promoter region.  Proteins were in vitro phosphorylated using beads fused 
to the cytosolic portion of PmrB, as described previously (Guckes et al., 2013). Post-
phosphorylation, response regulators were incubated with DNA in binding buffer (final 
concentration: 20mM Tris-HCl, 5mM MgCl2, 5mM KCl, 10% glycerol) for 20 minutes at room 
temperature. Reactions were loaded onto a 5% acrylamide non-denaturing gel. Electrophoresis 
was performed for 2.5 hours at 50V.  Gels were dried at 80°C for 2 hours before being exposed 
to X-ray film at -80°C. 
 
	 45	
qPCR  
Cultures were grown to log phase at 37°C with shaking before adding 100µM ferric iron.  
To collect samples at various time points after the stimulus, the culture was temporarily moved 
to room temperature, statically and subsequently returned to shaking at 37°C between time 
points. RNA was extracted from bacteria using the RNeasy kit (Qiagen), DNase-treated using 
Turbo DNase I (Ambion), and reverse transcribed using Superscript II Reverse Transcriptase 
(Invitrogen).  DNAse-treated RNA samples not subjected to reverse transcription were used as 
negative controls.  qPCR was performed in triplicate with two different amounts of cDNA (50 ng 
and 25 ng per reaction). cDNA was amplified using gfp and rrsH specific primers.  Relative fold 
change was determined by the ∆∆Ct method where transcript abundances were normalized to 
rrsH abundance (Pfaffl, 2001).  Quantitative real time PCR was performed using an ABI 
StepOne Plus Real Time PCR machine, using multiplexed TaqMan MGB chemistry. 
Experiments were performed with at least three independent biological replicates. 
 
Polymyxin B sensitivity assay 
Bacteria were grown overnight at 37°C with shaking.  Overnight cultures were then sub-
cultured into N-minimal media with or without 100 µM ferric chloride.  Once N-minimal 
cultures reached mid-logarithmic phase of growth, cultures were normalized to an OD600 of 0.3 
in 1X PBS and incubated with or without 2.5 µg/mL polymyxin B at 37°C for 1.5 hours.  
Cultures were plated on LB agar to determine CFU/mL.  Percent survival was calculated by 
dividing the number of bacteria that grew post-exposure to polymyxin B by the number of 
bacteria that grew after incubation in PBS alone, and multiplying by 100.  Statistical analysis 
comparing percent survival between strains were performed using a non-parametric one-way 
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analysis of variance by the Kruskal-Wallis test, P<0.01. All statistical analyses were performed 
using GraphPad Prism software. 
 
Results 
All components of the QseBC and PmrAB TCSs are required for proper response to ferric iron 
Signal detection by bacterial sensor histidine kinases, typically leads to a surge in 
phosphorylated response regulator, which in turn alters the expression of target genes within a 
very short timeframe (Shin et al., 2006).  In response to an incoming stimulus, there is a rapid 
phosphotransfer event from the cognate sensor kinase, which within 5-10 minutes, culminates to 
maximal phosphorylation of the cognate response regulator. For TCSs that are able to auto-
regulate their expression, the phosphorylated response regulator is able to act as an activator of 
transcription, and this series of events is referred to an activation surge (Shin et al., 2006). The 
changes in transcription of known target genes over time can be followed using qPCR. 
We have previously reported that in UPEC, stimulation with ferric iron induces the 
qseBC operon, in a manner that appears to involve PmrA and QseB (Guckes et al., 2013).  To 
better define this transcriptional control, we measured the activity of the qseBC promoter 
immediately prior and immediately after exposure to 100 µM ferric iron in UPEC strain UTI89 
and various isogenic pmr and qse mutants using qPCR. Samples from bacteria grown in N-
minimal media were obtained from 0 to 60 minutes post exposure to ferric iron, and qPCR 
analysis was performed measuring the transcriptional surge of the qseBC promoter over time 
(Fig. 11). These experiments revealed that in wild-type UTI89, a robust surge in steady-state 
transcript was observed by 15 minutes post stimulus addition (Fig. 11). These results 
corroborated previous reports tracking the transcription of PmrA-regulated targets in Salmonella 
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(Shin et al., 2006). However, contrary to what has been reported for Salmonella (Merighi et al., 
2009), the absence of QseB, QseC, PmrB, or PmrA abolished the transcriptional spike seen at 15 
minutes (Fig. 11). These data implied that in the case of UPEC, all components are required to 
drive expression of qseBC in response to the ferric iron stimulus.  
Previous studies indicated that QseC kinase activity is enhanced in response to 
epinephrine, norepinephrine and auto-inducer 3, a bacterial putative quorum signaling molecule 
of unknown structure (Clarke et al., 2006). We have demonstrated QseC readily auto-
phosphorylates and phosphotransfers to QseB, even in the absence of signal, a behavior that is 
unlike typical histidine kinases (Fig. 12A and (Guckes et al., 2013; Kostakioti et al., 2009). In 
vitro phosphotransfer assays indicated that the addition of epinephrine (Fig. 12A), 
norepinephrine, or spent UPEC supernatant fractions did not increase QseC kinase activity 
towards QseB under the conditions tested, contrary to what would be expected if epinephrine 
were a signal for this system. Furthermore, it appears that epinephrine decreased the rate of 
phosphotransfer or increases the rate of de-phosphorylation by QseC under the conditions tested 
(Fig. 12A-C). Subsequent analyses probing for changes in qseB gene transcript in the presence of 
epinephrine indicated no differences in qseB steady-state transcript in the presence or absence of 
epinephrine in wild-type UTI89 or in a strain lacking the qseC gene (Fig. 12D). The qseC 
deletion mutant, UTI89ΔqseC, consistently had high qseB transcript levels, consistent with 
unregulated PmrB phosphotransfer to QseB (Guckes et al., 2013). Together, these results 
indicated that in UPEC, epinephrine and norepinephrine do not stimulate the kinase activity of 
the QseC sensor kinase and that QseBC is involved in proper stimulus response to ferric iron in 
conjunction with PmrAB. 
	 48	
We then probed whether PmrA- or QseB- mediated the activation surge in Fig. 11 was specific 
to stimulation with ferric iron, or whether other cations would elicit the same response. To test 
the specificity of the coordinated response to ferric iron, zinc chloride and copper sulfate were 
used as sources of zinc (Zn2+) and copper (Cu2+). These metal cations were chosen, based on 
previous studies listing high concentrations of extracellular zinc (II) as a putative signal for E. 
coli PmrB (Lee, Barrett, & Poole, 2005) and toxic ions including cesium, cobalt, copper, nickel, 
and ruthenium causing hypersensitivity in E. coli strains lacking QseBC (Zhou, Lei, Bochner, & 
Wanner, 2003). We tested the steady-state transcript abundance of qseB using a probe-based 
TaqMan qPCR approach that was similar to the approach employed to measure the responses to 
ferric iron (Fig. 11). Only the presence of ferric iron resulted in observed typical transcriptional 
surge (Fig. 11), while zinc cations led to a modest and consistent increase in the abundance of 
qseB transcript, that were maintained overtime and did drop to baseline levels (Fig. 13, green 
squares). Addition of copper cations steadily increased the amount of qseB transcript overtime, 
reaching maximal transcription at 60 minutes post-stimulation (Fig. 13, blue circles), suggesting 
that qseBC may be downstream of a different copper-responsive regulator. Based on these 
observations, we evaluated protein-protein interactions and downstream regulatory events in 
response to ferric iron.   
 
PmrB phosphotransfers to PmrA and QseB upon stimulation with ferric iron 
The studies summarized in Fig. 11 indicated a strong surge in qseBC transcript in 
response to ferric iron that only occurs when the QseBC and PmrAB systems are intact. These 
studies also suggested that signal interception occurs through PmrB and likely transduced by 
phosphorylation to the two response regulators. We have previously shown that PmrB  
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Figure 11. All components of both TCSs are required for qseBC transcriptional surge in 
response to ferric iron.  
 
Graph depicts quantitative real-time PCR (qPCR) measuring gfp steady-state transcript 
abundance, which reports qseBC promoter activity using a Pqse::gfp fusion construct. gfp mRNA 
abundances were measured by TaqMan qPCR. Fold changes were calculated using the ΔΔCT 
method, where rrsH was used as an endogenous control and samples were normalized to time0. 
Fold changes are graphed on a log2 scale. Error bars indicate SEM; experiment performed at 
least three times.  
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Figure 12. QseC activity is not enhanced in the presence of epinephrine.  
 (A-B) Panels depict radiographs that track auto-phosphorylation and subsequent 
phosphotransfer of 32P-γATP to QseB by QseC in the absence (A) and presence (B) of 100 µM 
epinephrine (Epi). Images are representative of at least 3 biological replicates. Detailed methods 
regarding the phosphotransfer experiments are described in the materials and methods section.  
(C) Representative quantitation of phosphorylated QseB (QseB~P) in the presence (Closed 
circle) and absence (open circle) of 100 µM epinephrine (Epi) using image J. (D) Representative 
qPCR analysis tracking the relative fold change of qseB transcript for wild type UTI89 (squares) 
and UTI89ΔqseC (triangles) in the presence (closed shape) and absence (open shape) of 100 µM 
epinephrine (Epi). Fold changes are graphed on a Log2 scale.  
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Figure 13. The qseBC transcriptional surge is specific to ferric iron.  
Graph depicts qPCR measuring qseB steady-state transcript levels for UTI89 in N-minimal 
medium without any additional metals (open circles), UTI89 in the presence of copper (blue 
circle Cu2+), and UTI89 in the presence of zinc (green square Zn2+). Fold changes were 
calculated by the ΔΔCT method, where rrsH was used as an endogenous control and samples 
were normalized to matching time points of UTI89 in the absence of signal. Fold changes are 
graphed on a Log2 scale. Error bars indicate SEM between 3 biological replicates. 
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indiscriminately phosphotransfers to QseB in the absence of signal (Chapter II; (Guckes et al., 
2013).  Here we evaluated how the kinetic activity of UPEC PmrB towards PmrA and QseB 
inthe presence of ferric iron. For these studies, tagged PmrB was expressed in strain UTI89 and 
membrane fractions were prepared as previously described (Kostakioti et al., 2009). Notably, 
UTI89 PmrB sequence harbors 98% nucleotide identity and 99% protein sequence identity to 
previously tested, non-pathogenic E. coli strain K12 (Table 1, Clustal Omega). In the absence of 
signal, UPEC PmrB exhibited strong phosphatase activity towards PmrA (Fig. 14A and Fig. 
14E), consistent with previous reports evaluating PmrB activity in non-pathogenic E. coli, and 
consistent with the typical mechanism of action for signal-responsive kinase-phosphatases. PmrB 
indiscriminately phosphorylated the non-cognate response regulator QseB, in the absence of 
signal (Fig. 14C, and Fig. 14E), as we previously reported, indicating that in the absence of 
signal, PmrB can interact appropriately only with its cognate partner (Guckes et al., 2013).  
When the phosphotransfer assays were repeated with 100µM ferric iron added to the 
reaction buffer, enhanced PmrB phosphotransfer was observed towards both PmrA and QseB 
(Fig. 14B, Fig. 14D, and Fig. 14F). On average, maximal phosphorylation of the response 
regulators was observed 10 minutes following addition of stimulus, with the highest rate of 
phosphorylation occurring within the first 2 minutes of the reaction (Fig. 14F). These data 
indicated that presence of stimulus changes the kinetic behavior of PmrB towards both the 
cognate (PmrA) and the non-cognate (QseB) partners. 
 
QseB and PmrA co-direct the expression of ferric iron-regulated targets 
We then assessed whether PmrA and QseB are both required for optimal expression of 
yibD, another ferric iron-stimulated target that has been shown to influence LPS modification in  
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Figure 14. PmrB phospho-transfer activity is enhanced in the presence of ferric iron. 
(A-B) Panels depict radiographs that track auto-phosphorylation and subsequent phosphotransfer 
of 32P-γATP to PmrA by PmrB in the absence (A) and presence (B) of 100 µM ferric iron (Fe3+). 
Images are representative of at least 3 biological replicates. (C-D) Panels depict radiographs that 
track auto-phosphorylation and subsequent phosphotransfer of 32P-γATP to QseB by PmrB in the 
absence (C) and presence (D) of 100 µM ferric iron (Fe3+). Images are representative of at least 
three biological replicates. Detailed methods regarding the phosphotransfer experiments are 
described in the materials and methods section. (E-F) Graphs depict representative quantitation 
of phosphorylated response regulators (RR) PmrA (PmrA~P, squares) and QseB (QseB~P, 
triangles) using image J in the absence (E open shapes) or presence (F, closed shapes) of 100 µM 
ferric iron (Fe3+). Relative intensities are graphed on a Log2 scale. Details on the analysis are 
provided in the materials and methods. 
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Table 1: QseB and QseC protein sequence identity amongst E. coli strains and other enteric 
bacteria.  
Strain QseB protein 
sequence 
identity (%) 
GenBank 
accession number 
QseC protein 
sequence 
identity (%) 
GenBank accession 
number 
E. coli 
UPEC str. UTI89 100 ABE08897.1 100 ABE08898.1 
APEC O1K1 str. 
O1                      
100.00   ABJ02530.1 100.00 ABJ02531.1 
B2 phylogenetic 
group: O83:H1 
100.00 YP_006121348.1 98.89 YP_006121349.1 
D1 phylogenetic 
group: UMN026 
100.00 YP_002414171.1 98.89 YP_002414172.1 
D2 phylogenetic 
group: 
 IAI39 
100.00 YP_002409426.1 98.22 YP_002409427.1 
  
UPEC str. CFT073 99.54   AAN82208.1 98.89 AAN82209.1 
K12 str. MG1655 99.54   NP_417497.1 98.89  NP_417498.1 
B1 phylogenetic 
group: O104:H4 
99.54   AFS72693.1 98.22 AFS72692.1 
EAEC str. 
E55989 
99.54   CAU99558.1 98.22 CAU99560. 
EHEC str. EDL933 99.54  AIG70396.1 98.22 AIG70397.1 
EPEC O55:H7 str. 
CB9615 
99.54   ADD58237.1 98.22 ADD58238.1 
  
O157:H7 str. Sakai  
Sakai* 
99.54 NP_311934.1 97.13 / 98.55  NP_3909913-
3910437 
NP_3910431-
3911261   
ETEC O139:H28 
str.  E24377A                
99.07   ABV19769.1 98.22 ABV17955.1 
Additional enteric bacteria 
Shigella sonnei str. 
Mosely                
100.00   EJL13232.1 
  
99.11 EJL13233.1 
Salmonella 
enterica 
Typhumurium str. 
LT2   
87.67   NP_462092.1 79.29 NP_462093.1 
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Salmonella 
enterica 
Typhumurium  str. 
14028S 
87.67 ACY90252.1 79.29 ACY90253.1 
Klebsiella 
pneumoniae 
str. 342   
83.11   ACI08570.1 67.04 ACI08526.1 
Edwardsiella tarda 74.89 
  
ADO13165.1 56.35 ADO24152.1 
 
*Sakai has a stop codon in the middle of this putative QseC sequence rendering QseC 
non-functional in this strain.  
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Salmonella enterica (Merighi et al., 2009; Tamayo et al., 2002). The promoter of UPEC-encoded 
yibD also contains a PmrA binding consensus and is bound by PmrA in in vitro assays (Guckes 
et al., 2013). Analysis of yibD expression in response to ferric iron revealed that, compared to 
wild-type UTI89, deletion of pmrA abolished expression, while deletion of qseB reduced the 
yibD transcriptional surge by five-fold (Fig. 15). Subsequent electrophoretic mobility shift assays 
(EMSAs) indicated that PmrA and QseB could each physically engage the yibD promoter, albeit 
with different binding affinities (Fig. 16). In vitro phosphorylated PmrA (PmrA~P) caused a 
discernible shift in DNA at a concentration of 30pmol of purified protein, while in vitro 
phosphorylated QseB (QseB~P) was able to directly bind the yibD promoter at a concentration of 
100 pmol (Fig. 16). This binding was shown to be specific as unlabeled yibD promoter was able 
to titrate both QseB and PmrA protein from labeled promoter (Fig. 16). 
 
PmrA and QseB mediate UPEC tolerance to polymyxin B 
In Salmonella enterica, the PmrAB TCS was shown to mediate lipopolysaccharide (LPS) 
modifications to buffer against damage due to antimicrobial peptides like polymyxin B (PMB) 
(Kato et al., 2012). Another TCS, PhoPQ, has been shown to coordinate with PmrAB to 
contribute to the control of LPS modifications in response to increased decreased magnesium 
ions (Kato et al., 2012). However, the same coordination between PmrAB and PhoPQ has not 
been shown in E. coli (Winfield & Groisman, 2004). E. coli strains not harboring the mcr-1 
plasmid typically show susceptibility to PMB and colistin. When we tested UTI89 and mutants 
deleted for components of QseBC, PmrAB and PhoPQ for PMB sensitivity in the absence of pre-
stimulation with ferric iron, we observed that minimum inhibitory concentrations (MICs) to 
PMB were similar between wild-type and mutants lacking the entire QseBC, PmrAB, or PhoPQ  
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Figure 15. Additional targets controlled by both PmrA and QseB response regulators. 
qPCR depicting transcriptional surge of yibD in response to ferric iron.  gyrB was used as an 
endogenous control to calculate ΔΔCT  values compared to each strain’s time0. Error bars 
indicate the SEM of three biological replicates.  
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Figure 16. PmrA and QseB binding to the yibD promoter is specific. 
(A) EMSA using labeled yibD promoter DNA using indicated amounts of in vitro 
phosphorylated PmrA and QseB. (B) EMSA showing 100 pmol of in vitro phosphorylated PmrA 
or QseB binding to the labeled yibD promoter DNA with increasing concentrations of unlabeled 
promoter. Blots are representative of at least three biological replicates.  
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TCSs (Fig. 17) indicative of overall baseline susceptibility of UPEC to PMB.  However, strain 
UTI89ΔqseCΔpmrA, which positively biases cross-interaction between PmrB and QseB, had a 
statistically significant increase in PMB tolerance (Fig. 17). This increase in MIC observed with 
the ΔqseCΔpmrA mutant was unchanged with the additional deletion of phoPQ (Fig. 17).  
However, when qseB was additionally removed from the ΔqseCΔpmrA mutant, the MIC returned 
to wild-type susceptibility concentrations.   
Previous studies by Winfield and Groisman indicated that pre-treatment of E. coli with 
sub-lethal concentrations of ferric iron boosted tolerance to PMB (Winfield & Groisman, 2004). 
Given the increased tolerance when PmrB and QseB were isolated (ΔqseCΔpmrA mutant), and 
the observed ability of PmrB to phosphorylate both PmrA and QseB in response to ferric iron, 
we asked whether pre-treatment of ferric iron would prime UPEC to prevent damage due to 
PMB in a PmrA-QseB-dependent manner. To test this, wild-type UTI89 and isogenic pmr and 
qse mutants were grown in the presence or absence of ferric iron for two hours, after which they 
were exposed to 2.5 µg/mL PMB, and subsequently assessed for survival. As a control, 
Salmonella enterica serovar Typhimurium strain 14028 was included in the studies, since it has 
previously been shown that Salmonella tolerance to PMB increases after incubation with ferric 
iron in a PmrAB-PhoPQ dependent manner (Winfield & Groisman, 2004). These studies 
revealed that, consistent with previous observations, Salmonella had a higher overall tolerance to 
PMB, even in the absence of ferric iron conditioning. Conditioning with ferric iron prior to 
exposure to PMB resulted in 75% survival for WT UTI89, a value that is comparable to 
tolerance exhibited by Salmonella (Fig. 18). In contrast, the ΔpmrA mutant exhibited decreased 
survival to 20%, while the mutant lacking QseB exhibited even greater reduction in survival, 
declining to about 10% compared to pre-treated WT UTI89.  The mutants lacking both pmrA and  
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Figure 17. Minimum inhibitory concentrations of polymyxin B. 
Minimum inhibitory concentrations for polymyxin B without pre-treatment of bacteria with 
ferric iron were calculated for indicated strains using Etest strips (Biomerieux).  Experiments 
were performed a minimum of four times, where error bars represent standard error of the mean 
(SEM). Statistical analyses were performed using a two-way ANOVA with a Tukey multiple 
comparison test, where ****, P≤0.0001.   
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Figure 18. Polymyxin B resistance is enhanced in a PmrAB and QseB dependent manner. 
Graph reports UPEC tolerance to 2.5 µg/mL polymyxin B with or without ferric iron pre-
conditioning. “-Fe3+” indicates cells grown in N-minimal media without additional ferric iron 
before exposure to polymyxin B.  “+Fe3+” indicates cells grown in N-minimal media with 
100µM ferric iron before exposure to polymyxin B.  Survival was calculated by dividing the 
number of CFUs recovered after polymyxin B incubation by the number of CFUs recovered after 
incubation in PBS alone. Error bars represent SEM of three biological replicates. Statistical 
analyses were performed using Two-Way ANOVA with Bonferroni post-test. P values indicated:  
*, P<0.05; **, P≤0.01; ***, P≤0.001; ****, P<0.0001. Additionally, the survival ratio between 
paired batches of pre-conditioned and non-conditioned bacteria were compared across strains 
and were shown to be statistically significant using a non-parametric one-way analysis of 
variance by the Kruskal-Wallis test, P<0.01. All statistical analyses were performed using 
GraphPad Prism software. 
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qseB genes had survival percentages comparable to those seen in the ΔpmrB mutant.  Deletion of 
phoPQ did not significantly alter UTI89 survival (Fig. 18), indicating that pre-conditioning with 
ferric iron raises UPEC tolerance to PMB through coordinated regulation of downstream targets 
by PmrAB and QseBC and without regulatory input by PhoPQ.  
To determine if this phenotype was strain-specific, we tested various other strains of 
extraintestinal E. coli (ExPEC), including well-characterized strains EC958 and CFT073, as well 
as urinary isolates collected from the Vanderbilt University Hospital.  PMB tolerance post-ferric 
iron conditioning was variable among the different strains. Vanderbilt urinary tract isolates 
(VUTI) 39, 47, 61 and 77, as well as CFT073 exhibited increases in tolerance post-ferric iron 
treatment, with VUTI77 and CFT073 having the highest tolerance (Figure 19). However, 
VUTI61 and EC958 exhibited no difference in PMB susceptibility, suggesting that the observed 
effects with PMB are not strain-specific, but are also not universally conserved among urinary 
isolates. Taken together, our analyses have uncovered a previously uncharacterized interaction 
between PmrA and QseB that mediates resistance to polymyxin B in a subset of E. coli strains.  
 
Discussion 
 
  In work described in this chapter, we sought to determine whether there is a condition in 
which PmrAB and QseBC physiologically interact.  We found that in contrast, to the previously 
reported cross-interacting TCSs (Matsubara et al., 2000; Howell et al., 2006; Rabin et al., 1993; 
Drepper et al., 2006; Schröder et al., 1994), QseBC-PmrAB interactions are mediated by a single 
stimulus, which culminates in kinetically equivalent phosphorylation of two response regulators, 
at least based on in vitro phosphotransfer assays (Figs. 14 and 20).  
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Figure 19. Polymyxin B tolerance post-ferric iron conditioning is variable among ExPEC 
strains. 
 
Graph depicts UPEC tolerance to 2.5ug/mL polymyxin B with or without ferric iron pre-
conditioning. “-Fe3+” indicates cells grown in N-minimal media without additional ferric iron 
before exposure to polymyxin B.  “+Fe3+” indicates cells grown in N-minimal media with 
100µM ferric iron before exposure to polymyxin B. Survival was calculated by dividing the 
number of CFUs recovered after polymyxin B incubation by the number of CFUs recovered after 
incubation in PBS alone, and multiplying by 100. Error bars represent SEM of three biological 
replicates.  
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Here, there was an equally rapid increase in phosphotransfer from PmrB to PmrA and QseB in 
the presence of ferric iron (Fig. 14). This response was specific to ferric iron and did not appear 
to involve PhoPQ, which has been proposed to physically interact with cationic polypeptides 
such as PMB ((Figs. 17 and 18 and (Gunn et al., 1998; Hicks et al., 2015). Notably, no QseBC- 
(PreAB-) independent (Merighi et al., 2009), it is important to note that epinephrine, and other 
interaction between the two TCSs was observed with the reported QseC signal, epinephrine (Fig. 
12). While the effects of epinephrine on motility in Salmonella were previously rendered 
catechols, can chelate ferric iron. Previous studies by Sánchez et al. and Merighi et al. have 
suggested that effects on Salmonella motility could be a product of iron availability rather than 
catecholamine presence, and our data in UPEC support this hypothesis.   
Combined our data also point to PmrB being the primary signal receptor, the activation of 
which leads to downstream activation of QseB and PmrA, at least in the case of UPEC.  
Therefore, as expected, deletion of pmrB abolished the qseBC transcriptional surge, consistent 
with PmrB being the sole ferric iron sensor in the QseBC-PmrAB circuit (Figs. 11 and 14). The 
involvement of QseC in mediating the proper surge and decline of the transcriptional responses 
to ferric iron is not yet clear; when QseC is absent, any qseBC transcriptional surge is obscured 
by constitutively high qseB expression (Fig. 14E). This suggests that QseC physically prevents 
PmrB-QseB interactions or resets the system via dephosphorylation.  How these types of control 
are overridden when PmrB detects the ferric iron signal remains unknown. QseC could be 
sequestering QseB from interacting with and being phosphorylated by PmrB unless signal is 
present. Both possibilities by which QseC could be contributing to this “four-component” system 
deviate from the current standard of bacterial two-component system biology. Another possible 
mechanism for QseC-mediated control of the ferric iron response is QseC hetero-dimerization 
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with PmrB, which would prevent aberrant phosphotransfer between PmrB and QseB until signal 
is detected and sensor kinase homodimers preferably form.  Sensor hetero-dimerization in 
bacterial pathogens has been reported at least once in the literature (Goodman et al., 2009), 
raising the possibility that pathogenic strains of bacteria have evolved distinct mechanisms for 
integrating signals and/or mediating distinct responses to an incoming stimulus that may be of 
import during infection. For example, in acute urinary tract infection, bacteria are starved for 
iron, as many studies have previously shown (Henderson et al., 2009), yet, at the same time, they 
have to be able to distinguish between the need for metals and detrimental cations deployed by 
the innate immune response that are catastrophic to bacterial membrane integrity.  It is also 
possible that ferric iron in this study merely acts as a proxy to the signal that is detected in vivo.  
This could emcompass a molecule produced by the bacteria in the gut or the host immune 
response.  UPEC infect the urinary tract, but can persist for long periods of time in the gut.   
QseBC-PmrAB interactions may mediate survival in the gastrointestinal niche or the urinary 
environment. Further in vivo analysis are required to address these possibilities.  Future studies 
will also focus on delineating the potential protein-protein interactions that could be contributing 
to the tight control of QseBC-PmrAB responses to ferric iron.  
While our transcriptional studies mostly focused on the qseBC operon, we observed 
similar interactions for an additional shared target, yibD.  This gene target was previously 
reported to be part of the extensive PmrAB regulon in Salmonella (Merighi et al., 2009; Kato et 
al., 2003).  To date, the only gene targets reported for QseB have been qseBC and flhDC (Clarke 
et al., 2005; Sperandio et al., 2002). Deletion of either response regulator attenuated the yibD and 
qseBC transcriptional surge in response to ferric iron (Fig. 15), suggesting that both of these gene 
targets are part of the QseBC-PmrAB regulon and that QseB augments transcription of yibD in 
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the presence of PmrA.  This is critical, given our studies investigating resistance mechanisms to 
PMB after ferric iron treatment increased survival of several E. coli urinary isolates.  Colistin is a 
last resort antibiotic for treating UTIs.  Our data suggest that in at least a portion of urinary 
isolates, intrinsic colistin resistance can be coaxed by ferric iron, and perhaps an unidentified 
bacterial or host derived molecule.  Ongoing studies described in Chapters IV and V of this 
thesis dissect the QseBC-PmrAB regulon in UPEC strain UTI89 and investigate single 
nucleotide polymorphisms (SNPs) in the qseBC promoter that contribute to signal response 
divergence among E. coli pathotypes and strains. 
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Figure 20.  Model of QseBC-PmrAB signal transduction in response to ferric iron.   
 
Ferric iron is sensed by the PmrB sensor kinase, which in turn, phosphorylates both the cognate 
PmrA response regulator and the non-cognate QseB response regulator.  
 
 
 
 
 
 
 
 
 
 
 
 
 
	 68	
CHAPTER IV 
 
QSEB AND PMRA RESPONSE REGULATORS COORDINATE TO MEDIATE QSEBC 
TRANSCRIPTIONAL CONTROL IN UPEC STRAIN UTI89 
 
Introduction 
E. coli are classified into 5 major phylogenetic groups or clades: A, B1, B2, D, and E 
(Clermont et al., 2000).   These groups have been defined based on nucleotide sequence 
comparisons among a core set of housekeeping genes (Sims & Kim PNAS 2011).  However, 
extensive horizontal gene transfer in different E. coli strains has led to the acquisition and loss of 
numerous genes, including those involved in virulence.  Therefore, some phylogroups are 
separated by as little as 3% nucleotide identity between housekeeping genes but as much as 50% 
of total genes contained within the genome (Sims & Kim, 2011). Phylogenetic group A is 
comprises strains that are non-pathogenic (Rijavec et al., 2008; Johnson et al., 2001).  The extra-
intestinal pathogenic E. coli (ExPEC) strains mostly belong to the phylogenetic group B2, with 
some strains within the phylogroup D (Johnson & Stell, 2000; Picard et al. 1999).  The majority 
of intestinal pathogenic E. coli strains are found within phylogroups B1, D, and E (Pupo et al., 
1997; Gordon et al., 2008).  No studies have been performed to evaluate diversity in the 
signaling pathways of the different E. coli pathotypes and/or among the different E. coli 
phylogroups. 
As explained in Chapter I, differences in the QseBC signaling cascade and output 
responses have been reported extensively between UPEC and EHEC (Guckes et al., 2013; 
Kostakioti et al., 2009; Clarke et al., 2006; Clarke et al., 2005).  One explanation for these 
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discrepancies may be the variations in responses and signals that are important to the survival of 
the bacteria in the urinary tract versus the gut.  Therefore, variations in the evolutionary 
pressures the different E. coli experience may manifest as divergence among E. coli QseBC 
signaling cascades. Additionally, Figure 19 depicts differences in the ability of ferric iron to 
induce increased PMB tolerance in clinical urinary tract isolates including UPEC and 
asymptomatic strains, demonstrating that the variation in QseBC signaling may also exist among 
ExPEC isolates, including UPEC and asymptomatic strains. Therefore, with the help of 
collaborators at the Broad Institute, we have begun mapping  
To address this gap in the field, we collaborated with Dr. Ashlee Earl’s group at the 
Broad Institute to begin mapping single nucleotide polymorphisms (SNPs) within the qseBC 
promoter among different E. coli strains, spanning all major phylogroups.  In parallel studies, we 
undertook a thorough analysis of the cis-elements of the qseBC promoter in UPEC strain UTI89.  
We have shown that PmrA and QseB upregulate qseBC transcription in response to ferric iron, 
and that this increase in transcription is an important upstream target of a pathway that leads to 
increased antibiotic tolerance (Fig. 16). Although our previous studies demonstrated that QseB 
and PmrA could individually bind the qseBC promoter, we have not extensively interrogated the 
interplay of the two proteins together in association with qseBC promoter DNA.  Here we 
describe studies that begin to dissect interactions PmrA,QseB, and promoter DNA. 
 
Methods 
Strains and Constructs 
All studies have been performed in the uropathogenic Escherichia coli strain UTI89 
(Mulvey et al., 2001) and isogenic mutants. Deletion strains UTI89ΔpmrA, UTI89ΔpmrB, 
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UTI89ΔpmrAB, UTI89ΔqseC, UTI89ΔqseB, UTI89ΔpmrAB and the quadruple mutant 
UTI89ΔpmrABΔqseBC have been previously created (Guckes et al., 2013; Kostakioti et al., 
2009; Hadjifrangiskou et al., 2011), using the method of Murphy and Campellone (2003). 
The previously constructed transcriptional reporter plasmid pPqse::GFP (Kostakioti et al., 
2009) was used as a template for site-directed mutagenesis to generate the PmrA binding site 
variants. Site-directed mutagenesis accomplished using an adapted method from the Agilent 
QuikChange II protocol as previously described (Kostakioti et al., 2009). 
 
Electrophoretic Mobility Shift Assays (EMSAs)  
EMSAs were performed as described as in Chapter III.  A representative of at least 3 
biological replicates is presented in each figure.  
 
Motility Assays  
Motility assays were performed as described in previous chapters where motility 
diameters were recorded for at least 5 biological replicates with at least 3 technical replicates per 
experiment. Statistical analysis was performed using one-way ANOVA with P<0.05 considered 
significant. 
 
Transcriptional Profiling by qPCR  
RNA was extracted using the Qiagen RNeasy kit and DNAse-treated as described in 
previous chapters.  One microgram of DNAse-treated RNA was subjected to reverse 
transcription, using Superscript II Reverse transcriptase and random hexamers (Life 
Technologies). qPCR was performed on 6.25 and 3.125 ng of cDNA to probe for relative 
transcript levels. Relative-fold change was determined using the ΔΔCT method of Pfaffl et al. 
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(2001), and statistical analyses on the expression levels obtained from at least three biological 
replicates were performed using one-way ANOVA, with P<0.05 considered significant. 
 
Genomic alignments 
 Forty-nine high-quality genomes representing pathogenic and non-pathogenic strains 
from each major clade (A, B1, B2, D, E, and Shigella) were used to construct phylogenetic trees 
using FastTree and RAxML (Price, Dehal, & Arkin, 2010; Stamatakis, 2014).  Alignments were 
made using UTI89 genome nucleotide coordinates shown in Table 2. 
 
        Table 2.  Nucleotide coordinates used in Pqse alignments. 
	 nt	coordinates from UTI89 genome 
(NC_007946.1)	
QseB 3387184-3387843 
QseC 3387840-3389189 
Pqse 3387024-3387183 
 
 
Results 
QseB and PmrA co-direct the expression of qseBC 
The binding consensus for PmrA is well described (Tamayo et al., 2002) and found 
within the qseBC promoter (Guckes et al., 2013). Analyses by Clarke et al. elucidated a loose 
QseB binding consensus within the qseBC promoter and this binding sequence lies 5 nucleotides 
away from the PmrA consensus (Fig. 21A). To ascertain the molecular interplay between QseB 
and PmrA on the qseBC promoter, we first examined the binding affinity of phosphorylated and 
un-phosphorylated QseB and PmrA on the qseBC promoter. Phosphorylation of response 
regulators allows the protein to assume a conformation that allows for more stable DNA binding 
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(Stock, 2000). Previously constructed phospho-mimetic (QseB_D51E) and phospho-inactive 
(QseB_D51A) QseB variants (Kostakioti et al., 2009) were used, as well as corresponding 
phospho-inactive (PmrA_D51A) and phospho-mimetic (PmrA_D51E) variants in PmrA, which 
were generated for this study.  
EMSAs revealed that in its un-phosphorylated form, QseB did not bind the qseBC 
promoter region (Fig. 21B), whereas productive binding could be seen with the phospho-mimetic 
variant, QseB_D51E, at concentrations as low as 50 pmol per reaction (Fig. 21C). This 
observation was consistent with typical response regulator binding ability activated by 
phosphorylation. Unlike QseB, PmrA did not require phosphorylation to bind the qseBC 
promoter (Fig. 21D-E), although PmrA_D51E had a higher affinity for the promoter causing a 
notable shift at 20 pmol of protein (Fig. 21D), compared to the 50 pmol required for 
PmrA_D51A (Fig. 21E). Combined, our results indicate that QseB requires phosphorylation to 
bind the promoter, while PmrA binds the qseBC sequence regardless of phosphorylation state.  
Because PmrB has been shown to phosphorylate PmrA and QseB in response to ferric iron (Fig. 
14), we also tested binding activity of phospho-mimetic PmrA when incubated with phospho-
mimetic QseB, simulating the situation that would occur in the presence of signal (Fig. 21F). 
Interestingly, the co-incubation of 30 pmol PmrA_D51E and an equimolar concentration of 
QseB_D51E with labeled qseBC promoter resulted in a DNA shift that was identical to the 
QseB-promoter migration pattern (Fig. 21F). Collectively, these data indicate the presence of 
PmrA~P somehow enhances QseB~P binding to its own promoter. 
 
QseB and PmrA stoichiometry dictates qseBC promoter control 
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Figure 21. PmrA stabilizes QseB-promoter interactions.  
 
A) Schematic depicting the reported binding sites for QseB (blue; Clarke et al., 2005) and 
hypothesized binding site for PmrA (red).  Numbers indicate distance from the transcriptional 
start sites. Bracket at the bottom indicates the portion of the promoter used for EMSAs in B-F. 
B) EMSA using radiolabeled qseBC and purified PmrA or QseB as indicated.  C) EMSA using 
radiolabeled qseBC and purified QseB_D51E (conformationally phosphorylated) D) EMSA 
using radiolabeled qseBC and purified PmrA_D51A (conformationally unphosphorylated) E) 
EMSA using radiolabeled qseBC and purified PmrA_D51E (conformationally phosphorylated). 
F) EMSA using radiolabeled qseBC promoter and both purified QseB_D51E and PmrA_D51E in 
pmol amounts indicated.   
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The baseline expression levels of pmrAB and qseBC have not been determined.  
Therefore how QseB and PmrA stoichiometry influences protein-DNA interactions in the 
presence and absence of signal remains unknown. To determine how altered PmrA levels would 
influence qseBC expression, we introduced pmrA extra-chromosomally and evaluated qseB 
steady-state transcript levels by qPCR. Consistent with previous observations, (Figure 7B), 
ΔqseC had significantly higher qseB transcript than WT, while the ΔqseCΔpmrA strain had 
intermediate transcript levels between those of WT and ΔqseC (Fig. 22A). Surprisingly, over-
expression of pmrA in the ΔqseCΔpmrA strain reduced the qseB transcript levels closer to WT, 
suggesting a suppressive effect when abundant (Fig. 22A).  
Given the lack of QseB phosphor-specific antibodies, motility were used as a proxy for 
active QseB levels.  Phosphorylated QseB is a known repressor of the flhDC flagella regulator 
(Kostakioti et al., 2009); therefore, an increase in qseB expression manifests as a motility 
decrease in soft agar. Consistent with the qPCR data, we observed and inverse relationship 
between motility and qseB expression (Figure 22).  The over-expression of PmrA_D51E or 
PmrA_D51A led to a reduction in qseB transcript and increase in motility, indicative that less 
QseB was produced in the presence of high levels of PmrA (Fig. 22B). Together, these data 
suggest that a complete lack of PmrA or over-expression of PmrA leads to decreased qseBC 
expression (Fig. 22). 
 
PmrA and QseB binding sites overlap 
In silico analysis and EMSAs demonstrating binding sites for PmrA and QseB, which 
appear to overlap. This overlap is likely to influence productive protein-DNA interactions and/or 
interactions of RNA polymerase with the promoter.  The PmrA binding site is made up of two  
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Figure 22. PmrA contributes to qseBC transcriptional control.   	
A) qPCR measuring gfp mRNA in strains containing a gfp fusion to the qseBC promoter.  rrsh 
was used as an endogenous control to calculate ΔΔCT  values compared to the WT strain. B) 
Motility assay reporting flagella expression via the distance bacteria swim through soft agar.  
Strains either contain an empty pTrc99a plasmid or a pTrc99a plasmid containing indicated 
phospho-variants of pmrA. Error bars represent SEM. Statistical analyses were performed by 
two-way ANOVA, where *, P<0.05; **, P≤0.01;***, P<0.001; ****, P<0.0001 where *, P<0.05; 
**, P≤0.01;***, P<0.001; ****, P<0.0001.	
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direct repeats, which is bound by PmrA dimers.  To further investigate this possibility, we altered 
the PmrA binding site consensus sequence, creating six different promoter mutants in which one 
or both of the direct repeats of the PmrA consensus sequence are altered (Figure 23A).  
Alterations in sequence were made to the repeat most proximal or distal to the QseB dependent 
transcriptional start, as well as both repeats (Figure 23A).  Figure 23A depicts the different 
promoter mutants, with mutations that affect sequence alone are shown in orange and mutations 
that affect both sequence and DNA topology are shown in pink.  
Binding of the resulting sequences with purified PmrA or phosphomimetic QseB was 
evaluated using EMSAs (Fig. 23B-D). As expected, PmrA binding affinity was decreased with 
any alteration to the consensus sequence (Figure 23B-D).  Interestingly, alterations affecting 
DNA topology and sequence at the most proximal repeat also decreased QseB affinity, 
suggesting that QseB binds closest to the proximal repeat within the PmrA consensus sequence 
(Fig. 23 B-C). However, alterations to sequence alone at the most distal repeat was able to 
increase QseB affinity (Fig. 23D). Mutations to the PmrA consensus sequence was able to alter 
both QseB and PmrA binding affinities, suggesting that binding sites for both proteins overlap 
(Fig. 23).  
 
Mutations in Pqse cluster within distinct E. coli phylogroups 
After evaluating rationally designed Pqse mutations (Fig. 23), we sought to identify 
naturally occurring variations in the qseBC promoter region among E. coli isolates.  To do this 
we worked with collaborators Ashlee Earl and Abigail Manson at the Broad Institute to align 
Pqse nucleotide sequences from 49 different E. coli strains.  The strains were chosen based on 
their genomic sequence quality as well as their diversity among the five different E. coli 
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phylogroups.  Figure 24 shows the generated phylogeny, which outlines the strain, pathotype, 
pathogenicity, and phylogroup. The tree also shows the four mutations that were identified 
within the Pqse sequence for each strain.  Of these mutations, mutations “1” and “2” were found 
only 4 strains, which suggests that these SNPs are less phylogenetically significant and less 
representative of the phylogroup as a whole (Fig. 24). However, mutation “3” is found in all of 
the group B2 strains, as well as three group D strains, which harbor the majority of UPEC 
strains, and Shigella.  Remarkably, mutation “4” clusters exclusively in group E strains, which 
typically harbor EHEC (Fig. 24).  The location of these mutations within the Pqse sequence is 
shown in Figure 25.  Mutation “3”, which is associated with the ExPEC in this phylogeny, lies 
just 4 nucleotides upstream of the -35 region of the previously reported constitutive 
transcriptional start site of qseBC (Fig. 25 and (Clarke et al., 2005)), while the EHEC associated 
mutation “4” lies directly downstream of the -10 region of the same transcriptional start site (Fig. 
25 and Clarke et al., 2005)).  These data show that there are naturally occurring SNPs within the 
qseBC promoter region that cluster with specific pathotypes of E. coli.  We are in the process of 
evaluating how these SNPs influence qseBC expression and PmrA and/or QseB interactions with 
the promoter. 
 
Discussion 
PmrA and QseB are both capable of binding the qseBC promoter in vitro; however, 
PmrA is able to bind in either the phospho-mimetic or phospho-inactive state (Fig. 21), 
suggesting that it could possibly be acting as a repressor of qseBC in the absence of signal.  
QseB was able to cause a discernible shift in the DNA in its phosphorylated state, suggesting that 
only QseB~P productively engages the qseBC promoter.  Moreover, stoichiometric amounts of 
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PmrA~P somehow enhanced QseB~P binding (Fig. 21F), suggesting that, in stoichiometric 
amounts, PmrA aids in stabilizing QseB – DNA interactions.  This could be due to differential 
binding of PmrA and PmrA~P.  PmrA~P may be positioned such that QseB~P interactions with 
the DNA are stabilized.  However, data in Figure 22 suggest that over-expression of PmrA leads 
to a decrease in qseBC transcript, potentially because PmrA has an inherently higher affinity for 
Pqse (Fig. 21B-D), out-competing QseB when in excess.  Congruent with this hypothesis, 
mutations made to the PmrA consensus sequence affect the binding of both response regulators 
suggesting that the proteins may hinder each other stoichiometrically and would not be able to 
bind Pqse simultaneously (Fig. 23).  
 The precise mechanism by which PmrA modulates qseBC transcription in conjunction 
with QseB~P remains unclear.  Absence of PmrA or QseB ablates the qseBC transcriptional 
surge (Fig. 11), and intermediate qseBC expression levels are observed in the ΔqseCΔpmrA 
mutant (Figs. 7B and 22), suggesting an activating role for PmrA, yet overexpression of PmrA 
shuts down qseBC transcription.  This paradox could be explained by the position of the PmrA 
binding consensus.  One of the tandem repeats precedes the -35 region for the more proximal 
transcription start site, while the other repeat is found within the -10 region. If only the repeat at 
the -35 region is bound, then PmrA may act as a class I activator, stabilizing RNA polymerase on 
the promoter to initiate transcription.  If the proximal repeat is occupied at the -10 region, this 
could inhibit RNA polymerase-promoter interactions, preventing transcription initiation. Future 
efforts will focus on dissecting protein-protein interactions between PmrA and QseB, as well as 
PmrA and RNA polymerase. Additional experiments are needed to determine how PmrA affects 
transcription of the two transcriptional start sites.  These experiments are outlined in detail in 
Chapter VI.   
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	 Naturally occurring SNPs within the qseBC promoter region suggest that the mechanism 
of qseBC transcriptional control may vary among different pathotypes of E. coli.   Notably, these 
SNPs cluster within distinct phylogroups associated with ExPEC and EHEC strains, which could 
potentially contribute to our understanding of how the QseBC signaling cascades may differ 
between UPEC and EHEC.  We are in the process of determining how SNPs in the qseBC 
promoter may influence QseB and PmrA interactions with the DNA and therefore affect 
downstream stimulus responses. 
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Figure 23. PmrA and QseB binding sites overlap.   
 
A) Schematic showing the mutations made in proximal qseBC promoter.  The QseB dependent 
transcriptional start site is shown in bold. The -10 and -35 regions are underlined.  The PmrA 
binding consensus sequence is shown in blue. Binding site variants are shown in varying colors 
(orange and pink). B-D) EMSAs using purified WT PmrA or phospho-mimetic QseB with 
radiolabled qseBC promoter containing various mutations in the predicted PmrA binding site. 
Graph represents binding as a ratio of mean pixel intensity of bound versus unbound.  
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Figure 24. Pqse mutations cluster to distinct phylogroups.   
 
Phylogeny of E. coli strains with corresponding Pqse mutations deviating from the consensus 
shown to the right.  All bootstrap values were above 90%, except for the two nodes indicated on 
the tree.  
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Figure 25. Schematic of naturally occurring Pqse mutations.  
The sequence shown is the UTI89 sequence.  Transcriptional start sites are shown in larger font.  
The -10 and -35 regions for the constitutive transcriptional start site are shown in bold, italics, 
and underlined.  The location of mutation 3 is shown in red, while the location of mutation 4 is 
shown in blue. The nucleotide at mutation 3 is a guanine in the A, B1, and E groups, and the 
nucleotide at mutation 4 is an adenine in group E strains.  
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CHAPTER V 
 
DELINEATING THE UPEC QSEBC-PMRAB REGULON IN RESPONSE TO FERRIC IRON  
 
Introduction 
 The previous chapters investigated the signal transduction pathway between PmrAB and 
QseBC in response to ferric iron.  The outcome of this signal transduction pathway is increased 
tolerance to PMB in several urinary E. coli isolates.  While the PmrAB regulon has been 
thoroughly delineated in Salmonella, downstream target genes regulated by QseB and PmrA that 
contribute to this phenotype in UPEC have yet to be elucidated.  In this chapter we used RNA 
sequencing (RNA-seq) to begin to delineate gene targets that are QseB- and PmrA-regulated in 
response to the ferric iron signal.   
 
Methods 
Bacterial strains 
All studies have been performed in the uropathogenic Escherichia coli strain UTI89 
(Mulvey et al., 2001) and isogenic mutants. UTI89ΔpmrA, UTI89ΔpmrB, UTI89ΔqseCΔpmrA, 
UTI89ΔqseC, UTI89ΔqseB, and UTI89ΔqseBΔpmrA (Guckes et al., 2013 PNAS; 
Hadjifrangiskou et al., 2011; Kostakioti et al. 2009). 
 
Sample collection 
 Cultures were grown to logarithmic phase in N-minimal media at 37°C with shaking 
before adding 100µM ferric iron.  To collect samples at various time points after the stimulus, 
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the culture was temporarily moved to room temperature, statically and subsequently returned to 
shaking at 37°C between time points.  Four milliliters were collected for each time point and 
subsequently used for RNA extraction via the RNeasy kit (Qiagen) and DNase-treatment using 
Turbo DNase I (Ambion). DNAse-treated RNA was then analyzed using a Qubit and 
Bioanalyzer.  All samples had an RNA integrity number (RIN) of at least 7 before being used for 
cDNA library construction.  Samples in this thesis are representative of one biological replicate.  
Analyses of a second replicate and collection of a third replicate are ongoing. 
 
RNA-sequencing and analysis 
 DNAse-treated RNA was submitted to the Vanderbilt Technologies for Advanced 
Genomics (VANTAGE) core.  VANTAGE performed mRNA enrichment using the Illumina 
Ribo-Zero kit and prepared cDNA libraries with the Illumina Tru-seq stranded mRNA sample 
prep kit.  Sequencing was performed at Single Read 50 HT bp on the Illumina HiSeq 2500.  With 
the help of collaborator Dr. Thomas Stricker, reads were aligned to the UTI89 genome 
(NC_007946.1) and subsequently subjected to k-means clustering analysis. 
 Gene lists for each cluster resulting from the k-means clustering analysis were generated 
using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) (Huang da, 
Sherman, & Lempicki, 2009). 
 
Results and Discussion 
Samples for RNA-seq were collected for UTI89 and six key isogenic mutants 
immediately prior as well as 15 and 60 minutes post-ferric iron stimulus. These time points were 
chosen based on the qseBC activation surge depicted in Figure 11, as 15 minutes post-stimulus 
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marks the peak of steady-state transcript levels for qseBC and 60 minutes post-stimulus shows a 
marked decrease in upregualtion, as the bacteria respond to the stressor and the TCS begins to 
“reset” (Shin et al., 2006).  At 60 minutes post-stimulus, QseB and PmrA downstream targets, 
such as yibD, begin to peak (Fig. 15). 
In addition to WT UTI89, the isogenic mutants were the following: (i) UTI89ΔpmrA and 
UTI89ΔqseB, lacking one of the two response regulators, (ii) UTI89ΔqseBΔpmrA, to decipher 
genes whose expression is altered in response to ferric iron, but not QseB and PmrA mediated, 
(iii) UTI89ΔpmrB to identify genes that are regulated independent of PmrB mediated signal 
transduction, (iv) UTI89ΔqseC as a control as this mutant has been previously evaluated for 
global transcriptional and metabolomic devations from the WT strain (Hadjifrangiskou et al.,  
2011), (v) UTI89ΔqseCΔpmrA to identify genes whose expression changes are solely due to 
PmrB-mediated QseB activation, as well as explore the transcriptional profile of a strain with 
inherent increased in resistance to PMB (Figure 17).   
 Transcript levels over time for all strains were grouped based on similar patterns of 
expression called clusters. Eight distinct clusters were extrapolated from the data (Figure 26).   
Cluster 1 mimics the pattern observed during an activation surge (Figs. 11 and 26).  Consistent 
with the qPCR in Chapter III (Fig. 11), both qseB and qseC can be found within Cluster 1 in WT 
UTI89.  Other cluster patterns include genes that are repressed over time (Clusters 2, 5 and 8), 
genes that are activated over time (Clusters 3, 4, and 7), and genes that are repressed and 
subsequently de-repressed (Cluster 6).   
 To further analyze these clusters, we began generating gene lists beginning with the WT 
strain using the DAVID online bioinformatics tool (Huang da, Sherman, & Lempicki, 2009).  
Table 3 depicts how genes from Cluster 1 were categorized into functional annotation summaries  
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Figure 26.  Gene expression clusters resulting from RNA-seq experiment. 
 
Clusters were generated using k-means clustering analysis.  Clusters are shown here as a type of 
heat map, where genes that do not fit the cluster pattern as tightly are shown in green, while 
those shown in blue and pink fit the cluster patter more tightly.  Numbers on the X-axis of each 
cluster indicate the time post-ferric iron stimulus in minutes. Expression changes are shown on 
the Y-axis. 
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using this bioinformatics tool. This portion of the data was chosen for initial evaluation given 
that our internal control, the qseBC transcriptional surge, mimics the Cluster 1 expression pattern  
(Fig. 11), and the qseBC activation surge is only observed for the WT strain. DAVID generated 
gene lists by grouping annotated genes from another database, KEGG, using common biological 
pathway terms.  Some genes are associated to multiple pathways, and thus appear in multiple 
pathway lists. There are at least 2 genes in each list. Not all genes from the WT strain within 
Cluster 1 are listed, only those which group with like pathway terms based on information pulled 
from the KEGG database.  
Most gene groups are consistent with pathways that are expected to be subject to swift 
transcriptional changes given the experimental conditions.  For example, as expected while 
replicating in minimal media, one of the functional gene groups is related to metabolism.  Also, 
consistent with rapid changes in transcription, one gene group consisted of genes predicted to 
code for proteins, which would bind DNA and/or regulate transcription.  Another expected 
category that appeared for WT bacteria in Cluster 1 was the ‘ion-binding’ pathway; however, the 
proteins found within this functional list are predicted to bind ions other than Fe3+.  The 
nucleotide-binding group is also unsurprising given most genes in that category are predicted to 
bind ATP; however, this group also interestingly includes a gene predicted to code for an 
ATPase associated with a type VI secretion system (T6SS). There was also a gene group 
containing genes related to bacteriophage replication. 
Initial comparisons were made by evaluating the differences in gene groups between WT 
Cluster 1 and the other six strains tested: ΔqseC (Table 4), ΔpmrB, (Table 5), ΔpmrA (Table 6), 
ΔqseB (Table 7), ΔqseBΔpmrA (Table 8), ΔqseCΔpmrA (Table 9). Tables 4-9 contain the genes 
within Cluster 1 gene groups that differed from those within WT Cluster 1 gene groups.  These 
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tables were generated with the same functional annotation gene clustering method using DAVID 
(Huang da, Sherman, & Lempicki, 2009).  
When comparing the ΔqseC strain with WT, Cluster 1 contains no differences in the 
genes within the phage group.  Though some differences were observed between the nucleotide-
binding group, the most differences can be seen in the genes within the metabolism group (Table 
4).  These differences observed between WT and ΔqseC the metabolism genes were expected 
given the known global metabolic differences between these strains in the absence of signal 
(Hadjifrangiskou et al., 2011).  
There were also differences observed in Cluster 1 metabolism group genes between 
ΔpmrB and WT.  Specifically the differences in metabolism included the presence of 
phosphotransferase system (PTS) genes, which are involved in sugar transport (Table 5). 
Interestingly, there was also an oxidoreductase Fe-S subunit gene that appeared in the ΔpmrB 
ion-binding group (Table 5).  Because ΔpmrB codes for the sensor that initiates the QseBC-
PmrAB downstream signaling in response to ferric iron, it is likely that this oxidoreductase 
expression is independent of the QseBC-PmrAB signaling cascade. The same gene predicted to 
encode this oxidoreductase Fe-S subunit is found in Cluster 1 for the ΔpmrA strain (Table 6), 
providing further evidence that this gene expression pattern is independent of QseBC-PmrAB 
ferric iron responses. 
The differences in Cluster 1 genes for strains deficient in the response regulators, ΔpmrA, 
ΔqseB, and ΔqseBΔpmrA, were mostly in the nucleotide-binding group or the transcriptional 
control group.  In contrast to what was observed in the strains devoid of either sensor kinase, the 
ΔpmrA strain had no differences in genes within the Cluster 1 metabolism group compared to 
WT. Though the ΔpmrA strain had no transcriptional control group differences compared to WT 
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within Cluster 1, ΔqseB, and ΔqseBΔpmrA share the same gene predicted to encode a LysR-
family transcriptional regulator (Tables 7-8). 
The greatest difference between ΔqseCΔpmrA and WT Cluster 1 gene groups are the 
genes contained within the phage group.  While the ΔqseC strain had three phage group genes 
that differed from WT in Cluster 1 (Table 4), ΔqseCΔpmrA had a remarkable 11 phage genes 
that differed from WT (Table 9).  Interestingly, there were no other strains that saw any phage 
gene differences compared to WT. 
 The data shown in Tables 3-9 and Figure 26 come from a single biological experiment.  
A second biological replicate has been sequenced and is in the process of being analyzed and 
collated with the first data set.  Samples will also be collected for a third biological replicate.  For 
fear of alterations in the content of the various clusters after acquiring sequencing data for all 
necessary biological replicates, the pathway analysis performed for Cluster 1 will be completed 
for all strains and clusters after all data has been coalesced.  
Additionally, it will be important to track genes of interest, such as those predicated to be 
involved in LPS modification, to determine if they associate with different clusters in the various 
isogenic mutants. We expect those genes to be in Clusters 4 or 7, following an expression pattern 
similar to that of yibD. Comparisons will be made across strains at specific time points during 
the ferric iron response, giving better insight as to which genes are controlled by the different 
QseBC and PmrAB components, either directly or indirectly. For example, given that the 
UTI89ΔqseCΔpmrA has a higher PMB MIC (Fig. 17), some LPS modification genes may be 
upregulated at all time points compared to the other isogenic mutants.   
 While the PmrAB regulon has been well studied in Salmonella enterica (Chen & 
Groisman, 2013), our experiments will provide valuable information about the PmrAB regulon 
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in pathogenic E. coli.  Additionally, unlike PmrA, which is predicted to bind 70 different 
promoters, QseB has thus far shown to directly bind only two promoter regions (Clarke et al., 
2006).  The full extent of the QseBC regulon is unknown, and these deep-sequencing 
experiments will provide insight as to which genes are directly or indirectly controlled by QseB.  
The most valuable insights will come from the comparisons between UTI89ΔqseB, 
UTI89ΔpmrA, and UTI89ΔqseBΔpmrA, as these will help to elucidate the QseBC-PmrAB 
regulon overlap.  
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Table 3.  Cluster 1 functional gene groups from the WT UTI89 strain  
 Metabolism group 
Locus Tag Gene Name Function 
UTI89_C4639 - Putative phosphorelay sensor kinase 
UTI89_C0380 - Putative nucleotidyltransferase 
UTI89_C1673 - Putative transferase 
UTI89_C1755 - Permease IIC component 
(Sugar phosophotransferase system) 
UTI89_C1756 - D-glucosamine phosphotransferase activity 
UTI89_C3971 - D-glucosamine phosphotransferase activity 
UTI89_C4001 - D-glucosamine phosphotransferase activity 
UTI89_C4003 - Putative xylulose kinase 
UTI89_C4004 - Putative phosphocarrier protein  
(Serine/threonine kinase activity) 
UTI89_C4202 - Putative transferase activity 
UTI89_C4206 - D-glucosamine phosphotransferase activity 
UTI89_C4207 - D-glucosamine phosphotransferase activity 
UTI89_C4208 - Putative transcriptional antiterminator 
UTI89_C4405 - Carbamate kinase 
(Arginine metabolic process) 
UTI89_C4587 - Putative phosphotransferase 
UTI89_C4588 - D-glucitol-6-phosphate dehydrogenase 
Nucleotide-binding group   
UTI89_C4639 - Putative phosphorelay sensor kinase 
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UTI89_C0832 gsiA Glutathione import ATP-binding protein 
UTI89_C0939 gpP Putative viral capsid assembly  
UTI89_C1138 - Hypothetical protein (GTP binding) 
UTI89_C2672 - Phage Nil2 gene P DnaB analogue 
(DNA helicase activity) 
UTI89_C3197 clpB Putative T6SS ATPase 
UTI89_C3693 rbsA Ribose transport ATP-binding protein 
UTI89_C4528 - Hypothetical protein 
(nucleotide catabolism) 
UTI89_C4634 sucC Succinyl-CoA ligase (ATP-binding) 
Ion-binding group   
UTI89_C3319 - Putative oxidoreductase 
(Binds Zn2+ ) 
UTI89_C4528 - Hypothetical protein 
(nucleotide catabolism) 
UTI89_C4634 sucC Succinyl-CoA ligase (ATP-binding) 
Phage group   
UTI89_C0939 gpP Putative viral capsid assembly  
UTI89_C1313 - Putative DNA packaging protein 
UTI89_C1498 - Putative DNA packaging protein 
Transcriptional control group   
UTI89_C0297 - Transcriptional regulator 
(MarR-family) 
UTI89_C2682 - Putative host FtsH protease inhibitor of phage 
Sf6 
UTI89_C3000 - Hypothetical 
(HTH domain) 
UTI89_C3216 - Putative transcriptional antiterminator 
UTI89_C4208 - Putative transcriptional antiterminator 
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Table 4.  Differences in Cluster 1 between WT and ΔqseC 
 Metabolism group 
Locus Tag Gene Name Function 
UTI89_C2218 - Acyl-CoA dehydrogenase 
UTI89_C2222 - Peptide/polyketide synthase 
UTI89_C2711 - Aminotransferase 
UTI89_C3183 - Cysteine sulfinate desulfinase 
UTI89_C3437 - Oxidoreductase 
UTI89_C3971 - Phosphotransferase system protein 
UTI89_C4955 - D-serine dehydratase 2 
Nucleotide-binding group   
UTI89_C1458 - Excisionase 
UTI89_C2218 - Acyl-CoA dehydrogenase 
UTI89_C2257 - Transposase 
Ion-binding group   
UTI89_C5104 - Hypothetical protein 
UTI89_C3274  Isopentenyl-diphosphate Delta-isomerase 
(Binds Mg2+ subunit) 
UTI89_C5104 - Hypothetical protein 
Phage group   
None   
Transcriptional control group   
UTI89_C0227 - LysR family transcriptional regulator 
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UTI89_C0683 - Transcriptional regulator 
UTI89_C0912  Hypothetical protein 
UTI89_C1556 - DEOR-type transcriptional regulator 
UTI89_C1757 - Hypothetical protein 	 	
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Table 5.  Differences in Cluster 1 between WT and ΔpmrB 
Metabolism group 
Locus Tag Gene Name Function 
UTI89_C3671 - P-hydroxybenzoic acid efflux pump 
UTI89_C4585 - PTS system mannose-specific transporter 
UTI89_C4586 - Sorbose PTS component 
UTI89_C1294 - Hypothetical protein 
UTI89_C1481 - DNA adenine methyltransferase 
UTI89_C4934 - Hypothetical protein 
Nucleotide-binding group   
UTI89_C1294 - Hypothetical protein 
UTI89_C1481 - DNA adenine methyltransferase 
UTI89_C2258 - Transposase 
UTI89_C2913 - Transposase 
UTI89_C4934 - Hypothetical protein 
Ion-binding group   
UTI89_C1863 - Oxidoreductase Fe-S subunit 
UTI89_C1997 - Hypothetical protein 
UTI89_C4527 - Hypothetical protein 
Phage group   
None   
Transcriptional control group   
UTI89_C2258 - Transposase 
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UTI89_C2958 - Hypothetical protein 
UTI89_C4417 - Putative transcriptional regulator 
UTI89_C4934 - Hypothetical protein 
UTI89_C4957 - Putative transcriptional regulator 
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Table 6.  Differences in Cluster 1 between WT and ΔpmrA 
Metabolism group 
Locus Tag Gene Name Function 
None   
Nucleotide-binding group   
UTI89_C1386 - ABC transporter ATP binding protein 
UTI89_C1458 - Excisionase 
UTI89_C2218 - Acyl-CoA dehydrogenase 
UTI89_C2257 - Transposase 
UTI89_C1386 - ABC transporter ATP binding protein 
UTI89_C1458 - Excisionase 
UTI89_C2218 - Acyl-CoA dehydrogenase 
UTI89_C2257 - Transposase 
UTI89_C1386 - ABC transporter ATP binding protein 
Ion-binding group   
UTI89_C2567 - NADH dehydrogenase subunit 
UTI89_C3253 - XdhC iron-sulfur-binding subunit 
UTI89_C3463 - Iron compound receptor 
UTI89_C4583 - Oxidoreductase 
Phage group   
None   
Transcriptional control group   
None   
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Table 7.  Differences in Cluster 1 between WT and ΔqseB 
Metabolism group 
Locus Tag Gene Name Function 
UTI89_C1099 - Aminotransferase 
UTI89_C1228 - PTS system protein 
UTI89_C1786 - Hypothetical protein 
UTI89_C2718 - Putative transport protein 
UTI89_C2997 - Hypothetical protein 
UTI89_C3214 - Beta-cystathionase 
UTI89_C4399 - PTS system protein 
UTI89_C4977 - Hypothetical protein 
UTI89_C5103 - Hypothetical protein 
Nucleotide-binding group   
UTI89_C1131 - Hypothetical protein 
UTI89_C2180 gsiA ABC transporter protein 
UTI89_C2257 gpP Transposase 
UTI89_C4671 - Oligopeptide ABC transporter protein 
UTI89_C1131 - Hypothetical protein 
UTI89_C2180 gsiA ABC transporter protein 
UTI89_C2257 gpP Transposase 
UTI89_C4671 - Oligopeptide ABC transporter protein 
UTI89_C1131 - Hypothetical protein 
Ion-binding group   
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UTI89_C1080 efeU Ferrous iron permease 
UTI89_C3459 - Iron ABC transporter 
Phage group   
None   
Transcriptional control group   
UTI89_C0317 - LysR family transcriptional regulator 
UTI89_C4624 - Putative regulator 
UTI89_C4653 - Putative transcriptional regulator 
UTI89_C4853 - Hypothetical protein 
UTI89_C4911 - Hypothetical protein 
  
	 101	
Table 8.  Differences in Cluster 1 between WT and ΔqseBΔpmrA 
Metabolism group 
Locus Tag Gene Name Function 
UTI89_C1564 - Bacterial cellulose biosynthesis 
UTI89_C2157 - Hypothetical protein 
UTI89_C4198 - Glutamate transport protein 
UTI89_C4207 - PTS system protein 
UTI89_C4387 - Threonine efflux system 
UTI89_C1564 - Bacterial cellulose biosynthesis 
UTI89_C2157 - Hypothetical protein 
UTI89_C4198 - Glutamate transport protein 
UTI89_C4207 - PTS system protein 
Nucleotide-binding group   
None   
Ion-binding group   
None   
Phage group   
None   
Transcriptional control group   
UTI89_C0317 - LysR family transcriptional regulator 
UTI89_C0750 - Hypothetical protein 
UTI89_C0965 - Bacteriophage Wphi phage protein 
UTI89_C4853 - Hypothetical protein 
	 102	
UTI89_C4973 - Hypothetical protein 
UTI89_C4975 - Hypothetical protein 
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Table 9.  Differences in Cluster 1 between WT and ΔqseCΔpmrA 
Metabolism group 
Locus Tag Gene Name Function 
UTI89_C0019 - Hypothetical protein 
UTI89_C1139 - Putative autotransporter 
UTI89_C1518 - Hypothetical protein 
UTI89_C2234 - Outer membrane receptor for iron compound 
UTI89_C3194 - Hypothetical protein 
UTI89_C4143 - Autotransport adhesin 
Nucleotide-binding group   
UTI89_C0242 - Hypothetical protein 
UTI89_C2218 - Acyl-CoA dehydrogenase 
UTI89_C2898 SrmB ATP-dependent RNA helicase 
UTI89_C3974 - Phosphoglycerate dehydrogenase 
UTI89_C4528 - Hypothetical protein 
Ion-binding group   
UTI89_C1863 - Oxidoreductase Fe-S subunit 
UTI89_C4465 - Dehydrogenase 
UTI89_C4528 - Hypothetical protein 
UTI89_C5064 yjjN Zinc-type alcohol dehydrogenase 
Phage group   
UTI89_C0038 - Transposase 
UTI89_C0563 - Prophage  
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UTI89_C0683 - Transcriptional regulator 
UTI89_C1267 - Prophage lambda integrase 
UTI89_C1350 - Hypothetical protein 
UTI89_C1437 InsG Transposase 
UTI89_C1694 - Hypothetical protein 
UTI89_C2204 - Prophage P4 integrase 
UTI89_C3458 - Hypothetical protein 
UTI89_C4475 - Hypothetical protein 
UTI89_C4934 - Hypothetical protein 
Transcriptional control group   
UTI89_C0683 - Putative transcriptional regulator 
UTI89_C1556 - DEOR-type transcriptional regulator 
UTI89_C3458 - Hypothetical protein 
UTI89_C4957 - Putative transcriptional regulator 
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CHAPTER VI 
 
FUTURE DIRECTIONS 
 
Introduction 
One of the main questions remaining in the bacterial TCS field is how bacteria are able to 
adapt to an ever-changing environment, filled with an overwhelming number of signals and 
stressors, using only a finite number of signaling networks.  The work presented in this thesis has 
focused on addressing this conundrum by investigating two cross-interacting TCSs, QseBC and 
PmrAB.  In contrast to other cross-interacting systems that have been reported, PmrB robustly 
phosphorylates both response regulators, including the non-cognate partner, QseB, in the 
presence of a single signal. Uniquely, all four components of these systems are required for 
proper regulation in response to signal, including QseC, which to date has not been shown to be 
directly involved in the PmrB mediated signal cascade.  Once PmrA and QseB are in their active 
form, they regulate genes that result in increased tolerance to PMB.  Current ongoing studies are 
focused on evaluating the extent of the regulon that is controlled by QseB and PmrA in response 
to ferric iron.  Additionally, questions still remain concerning the control of response regulator 
phosphorylation and expression, as well as the relevance of QseBC-PmrAB cross-interactions 
during infection.  This chapter centers on the future directions of this project concerning QseBC-
PmrAB regulation and their role in virulence. 
 
Future Directions 
QseBC-PmrAB regulon  
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 RNA-seq experiments to explore the QseBC-PmrAB regulon are ongoing.  Once all 
biological replicates have been assimilated, we can evaluate how genes of interest, such as those 
involved LPS modification like yibD, move to different Cluster patterns in the different qse/pmr 
mutants.  For example, if a subset of these LPS modification genes move from Cluster 4 in the 
WT to Cluster 8 in ΔqseB, implicating QseB as an important regulator for these genes.  Genes 
that move to different Clusters in ΔqseB, but not ΔpmrA for example, would be considered part 
of the QseB regulon, and not the PmrA regulon.  Gene lists will be generated based on how they 
change Clusters in the different isogenic mutants. Genes suspected to be part of the QseB and 
PmrA regulons by RNA-seq will be confirmed using qPCR and EMSAs. 
 
QseBC promoter control 
 As discussed in Chapter IV, the exact mechanism by which PmrA contributes to qseBC 
expression remains unknown.  The decrease in transcript levels in the ΔqseCΔpmrA mutant 
compared to ΔqseC (Fig. 7), suggests that PmrA is an activator.  However, over-expression of 
PmrA in ΔqseCΔpmrA leads to WT levels of motility and qseB steady-state transcript, 
suggesting that PmrA is a repressor (Fig. 22).  As discussed in Chapter IV, it is possible that 
PmrA represses one qseBC transcriptional start site, while activating the other, depending on 
which repeat is bound and/or in response to different growth conditions.  To test this hypothesis, 
primer extension experiments should be performed for the WT, as well as the ΔqseCΔpmrA and 
ΔqseC mutants. Additionally, primer extension should also be used to assess how the qseBC 
promoter region fires 15 minutes after WT bacteria have been exposed to the ferric iron signal, at 
the height of the transcriptional surge.  Results from these experiments will determine which 
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transcriptional start site is preferred when the signal transduction cascade is impaired when a 
when a qse/pmr components bacteria or when the bacteria are actively responding to signal. 
 Another unanswered question raised by results in Chapter IV concerns the ability of the 
QseB and PmrA response regulators to occupy the qseBC promoter region simultaneously.  
Initial EMSAs suggest that both proteins are unable to bind the promoter at the same time, likely 
due to steric hindrance (Fig. 21E and Fig. 23).  However, evidence shown in Chapter IV also 
suggests that PmrA may help to stabilize QseB interactions with its native promoter (Fig. 21). 
This would require QseB and PmrA to physically interact, at least temporarily, during 
transcription initiation.   Co-immunoprecipitation with recently raised PmrA antibodies, as well 
as Förster resonance energy transfer (FRET) or yeast two-hybrid experiments could be used to 
test if PmrA and QseB directly interact with one another.  Together these experiments would 
improve our understanding of a complex regulatory mechanism used to control the expression of 
components that comprise a unique bacterial signaling cascade. 
 
EHEC and UPEC differences in QseBC signaling 
 In Chapter IV, unique SNPs in the qseBC promoter region were found to associate with 
specific E. coli phylogroups that largely comprise UPEC or EHEC strains.  Given the differences 
in QseBC signaling reported between these two pathotypes of E. coli, studies should be 
conducted to test whether these SNPs contribute to the reported divergence in the QseBC 
signaling cascade.  Site-directed mutagenesis could be utilized to alter the Pqse::gfp construct to 
change the sequence to the EHEC sequence.  If these mutations are relevant to QseBC-PmrAB 
mediated ferric iron responses, qPCR would capture changes in the activation surge normally 
observed with the native UPEC promoter.  It is also possible that changes in the promoter 
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sequence could allow QseB or PmrA to engage the DNA differently in response to other signals, 
causing an activation surge in response to epinephrine.  
 
QseC involvement in proper signal responses 
 Previous work has established that in UPEC, the absence of QseC causes a dominant 
misregulation of over 500 genes (Hadjifrangiskou et al., 2011).  Chapter II describes that the 
additional deletion of the PmrB sensor kinase ablates this misregulation because PmrB would be 
unable to phosphorylate QseB.  Delays in phosphatase function (Fig. 6) from PmrB toward QseB 
provide a strong suggestion that de-phosphorylation of QseB is responsible for the over 
activation of QseB, leading to the aberrant gene regulation. Another hypothesis for how QseC 
prevents an accumulation of QseB within the bacterial cell by sequestering QseB, preventing 
PmrB from physically interacting with QseB.  Similarly, it is also possible that QseC interacts 
with PmrB as a heterodimer until signal is detected, freeing each sensor kinase to homodimerize 
and phosphorylate PmrA and QseB appropriately.  Experiments using co-immunoprecipitation to 
pull down PmrB and evaluating associated proteins would elucidate if PmrB physically interacts 
with QseC in the absence of signal. FRET could also be used to detect physical interactions 
between QseC and PmrB in vivo.  
 
Relevance of QseBC-PmrAB interactions to virulence 
 Although Chapter III provides evidence that QseBC-PmrAB cross-interactions provide a 
mechanism to tolerate cationic membrane stress (Fig. 18), these in vitro experiments do not 
comprehensively mimic the stressors UPEC encounter in a host.  It is more likely that UPEC 
experience cationic stressors such as the antimicrobial peptide LL-37, rather than ferric iron, in 
	 109	
the bladder.  Evidence provided in Chapter II shows that QseBC signaling is important to, UPEC 
virulence as strains lacking QseC are severely attenuated (Fig. 5).  However, the extent to which 
QseBC-PmrAB signaling contributes to UPEC adaptation and survival during cationic stress in 
the host has yet to be determined.   
 One way to evaluate if QseBC-PmrAB interactions are vital to survival during exposure 
to cationic stress is to test mutants deficient in various components of the TCSs in a chronic 
murine model of UTI.  During acute infection, UPEC are able to evade most stressors by 
invading the superficial umbrella cells in the bladder and forming IBCs (Anderson et al., 2003; 
Bower et al., 2005; Justice et al., 2004).  As infection progresses, these cells are exfoliated, 
leaving only immature urothelial that are not conducive to IBC formation (Thumbikat et al., 
2009).  Therefore, during a chronic infection, the bacteria remain extracellular and exposed to 
the host immune responses. Additionally, recurrent UTIs are thought to partially be caused by 
UPEC dwelling within patient gastrointestinal tract (Yamamoto et al., 1997), making the gut 
another extracellular niche for UPEC.   
 Initial studies to determine if QseBC-PmrAB interactions were important for UPEC to 
occupy the gut or urinary tract niches during chronic infection were performed using either WT 
UIT89, as well as a mutant with increased resistance to PMB, ΔqseCΔpmrA and a mutant 
deficient in both response regulators, ΔqseBΔpmrA.  Twenty female C3H/HeN mice per strain 
were transurethrally infected and urines and feces were collected for 13 days post-infection to 
track colonization and infection resolution (Figs. 27 and 28). Studies have demonstrated that 
urinalysis at 24 hours post-infection is predictive of chronic colonization if mice shed > 104 
bacteria per mL of urine.  Mice with high urine titers are separated fomr those predicted to 
resolve to prevent mice that have resolved their infection from becoming re-infected due to 
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coprophagic behavior. On day 14, the mice were sacrificed and bacterial burdens were calculated 
for bladders, kidneys, ceca, proximal colons, and distal colons (Fig. 29). 
 The bacteria recovered from urine and feces fluctuated over time for each strain.  
Interestingly, an increase in bacteriuria was observed in the double response regulator mutant, 
ΔqseBΔpmrA (Fig. 27).  A mild increase in UPEC within murine feces on day 13 was also 
observed for this strain (Fig. 28).  This increase in colonization could be due to lack of 
alterations in the LPS that could make the bacteria more likely to be detected by the host via 
Toll-like receptor (TLR)4.  This hypothesis should be investigated by using the ΔqseBΔpmrA 
mutant for transurethral infection of C3H/HeJ mice, which are deficient in TLR4. The only 
difference observed between WT and ΔqseCΔpmrA was a defect in fecal burdens at 10 days 
post-infection (Fig. 28).  Upon sacrifice at day 14, mice that were chronically infected with 
ΔqseBΔpmrA had higher amounts of bacteria in their kidneys compared to mice chronically 
infected with the WT strain; no differences were observed between the mutants and WT in the 
gut (Fig. 29).   
 Although not many significant defects were observed during this two-week experiment, 
other chronic models have extended infections out to 4 weeks. Extending the qse/pmr 
experiments to the 4-week point would be informative, especially when looking at bladder 
burdens as the two-week experiment shows a trend where the mutants seem to colonize better. 
Additionally, it would be interesting to investigate differences in immune responses to these 
various strains via cytokine profiling.  Differences in immune responses may help to explain the 
increase in ΔqseBΔpmrA seen in the urine compared to WT, as well as the increase in bladder 
colonization, although the colonization phenotype is not statically significant (Figs. 27 and 29). 
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Figure 27. Urinalysis of chronic mouse infection 
Mice were infected with 107 bacterial cells from WT UTI89, UTI89ΔqseBΔpmrA, or 
UTI89ΔqseCΔpmrA via transurethral inoculation.  Urines were collected from the mice on day 1, 
3, 7, 10, and 13 post-infection.  A) Scatter plot of colony forming units (CFUs) in urines of mice 
at indicated days post-infection.  After day 1, mice were sorted into ‘chronic’ or ‘resolved’ cages 
based whether the mice had more (chronic) or less (resolved) than 104 bacteria per mL in their 
urine.  B) The same data in the scatter plot was graphed as a line plot where each line represents 
a mouse that was deemed chronically infected, based on final bladder burdens that exceed 104 
CFU/mL. Lines represent mice infected with WT (black), ΔqseBΔpmrA (orange), and 
ΔqseCΔpmrA (purple). The dotted line just above 101 indicates the limit of detection for this 
assay.  Statistical analyses were performed using non-parametric Mann-Whitney test where * 
represents p ≤ 0.05; ** p ≤ 0.01. 
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Figure 28. Bacterial burdens in feces during chronic mouse infection 
Fecal samples were collected from the same mice depicted in Figure 27. A) Scatter plot of 
colony forming units (CFUs) in feces of mice at indicated days post-infection. B) The same data 
in the scatter plot was graphed as a line plot where each line represents a mouse.  The same data 
in the scatter plot was graphed as a line plot where each line represents a mouse.  Purple lines 
represent mice predicted to become chronic and orange lines represent mice predicted to resolve 
the infection based on day 1 urinalysis. The dotted line just above 101 indicates the limit of 
detection for this assay.  Statistical analyses were performed using non-parametric Mann-
Whitney test where * represents p ≤ 0.05; ** p ≤ 0.01. 
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Figure 29. Bacterial burdens in mice 14 days post-infection  
Mice were sacrificed at 14 days post-infection. Organs were harvested and homogenized and 
bacterial burdens were evaluated by counting CFUs/mL A-E) Bacterial burdens for indicated 
organs are shown as a scatter plot with geometric mean indicated by a solid horizontal line. The 
dotted line just above 101 indicates the limit of detection for this assay.  The dotted line just 
above 104 indicates the cutoff used to describe mice that were chronically infected.  Statistical 
analyses were performed using non-parametric Mann-Whitney test where * represents ** p ≤ 
0.01. 
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 Another possible contribution QseBC-PmrAB interactions may have to bacterial fitness is 
the ability to compete with other members of the normal microbiota.  All tested strains UPEC 
was able to colonize the gastrointestinal tract. Despite the lack of statistical differences between 
bacterial burdens in the gut at two weeks post-infection, recurrent UTIs occur over the course of 
months or years.  It is possible that QseBC-PmrAB signaling is important for maintaining 
colonization in these organs over a longer period of time.  Some evidence to support this comes 
from the RNA-seq experiment presented in Chapter V.  An ATPase associated with a T6SS, used 
for interbacterial competition, was found to have an expression pattern similar to qseBC in WT 
UTI89 during ferric iron exposure.  If this and other T6SS components are found to have 
expression patterns that fluctuate in the different qse/pmr mutants, this would suggest that T6SS 
expression is controlled by QseB and/or PmrA.  Interestingly, the qseBC operon lies within a 
gene cluster containing genes predicted to encode T6SS components.  It would be valuable to 
test mutants lacking various genes predicted to encode components of the T6SS in a chronic 
model of UTI.  These mutants would be predicted to have a colonization defect in the gut, where 
UPEC would have to compete with normal microbiota for nutrients and space.  Together these 
experiments would improve our understanding of a complex, unique bacterial signaling cascade 
and its relevance to pathogenesis. 
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